id	sid	tid	token	lemma	pos
gra-919	1	1	introduction	introduction	NOUN
gra-919	1	2	sepsis	sepsis	NOUN
gra-919	1	3	is	be	AUX
gra-919	1	4	a	a	DET
gra-919	1	5	leading	lead	VERB
gra-919	1	6	cause	cause	NOUN
gra-919	1	7	of	of	ADP
gra-919	1	8	mortality	mortality	NOUN
gra-919	1	9	and	and	CCONJ
gra-919	1	10	morbidity	morbidity	NOUN
gra-919	1	11	in	in	ADP
gra-919	1	12	neonates	neonate	NOUN
gra-919	1	13	,	,	PUNCT
gra-919	1	14	particularly	particularly	ADV
gra-919	1	15	in	in	ADP
gra-919	1	16	developing	develop	VERB
gra-919	1	17	countries	country	NOUN
gra-919	1	18	like	like	ADP
gra-919	1	19	india	india	PROPN
gra-919	1	20	where	where	SCONJ
gra-919	1	21	neonatal	neonatal	ADJ
gra-919	1	22	deaths	death	NOUN
gra-919	1	23	contribute	contribute	VERB
gra-919	1	24	70	70	NUM
gra-919	1	25	%	%	NOUN
gra-919	1	26	to	to	ADP
gra-919	1	27	the	the	DET
gra-919	1	28	total	total	NOUN
gra-919	1	29	under	under	ADP
gra-919	1	30	ve	ve	PROPN
gra-919	1	31	mortality	mortality	NOUN
gra-919	1	32	rate	rate	NOUN
gra-919	1	33	,	,	PUNCT
gra-919	1	34	and	and	CCONJ
gra-919	1	35	about	about	ADV
gra-919	1	36	30	30	NUM
gra-919	1	37	%	%	NOUN
gra-919	1	38	of	of	ADP
gra-919	1	39	all	all	DET
gra-919	1	40	neonatal	neonatal	ADJ
gra-919	1	41	deaths	death	NOUN
gra-919	1	42	are	be	AUX
gra-919	1	43	attributed	attribute	VERB
gra-919	1	44	to	to	ADP
gra-919	1	45	severe	severe	ADJ
gra-919	1	46	bacterial	bacterial	ADJ
gra-919	1	47	infections	infection	NOUN
gra-919	1	48	(	(	PUNCT
gra-919	1	49	1,2	1,2	NUM
gra-919	1	50	)	)	PUNCT
gra-919	1	51	.	.	PUNCT
gra-919	2	1	approximately	approximately	ADV
gra-919	2	2	750,000	750,000	NUM
gra-919	2	3	deaths	death	NOUN
gra-919	2	4	from	from	ADP
gra-919	2	5	neonatal	neonatal	ADJ
gra-919	2	6	sepsis	sepsis	NOUN
gra-919	2	7	occur	occur	VERB
gra-919	2	8	annually	annually	ADV
gra-919	2	9	worldwide	worldwide	ADV
gra-919	2	10	and	and	CCONJ
gra-919	2	11	99	99	NUM
gra-919	2	12	%	%	NOUN
gra-919	2	13	of	of	ADP
gra-919	2	14	these	these	PRON
gra-919	2	15	take	take	VERB
gra-919	2	16	place	place	NOUN
gra-919	2	17	in	in	ADP
gra-919	2	18	developing	develop	VERB
gra-919	2	19	countries	country	NOUN
gra-919	2	20	settings.(3	settings.(3	PROPN
gra-919	2	21	)	)	PUNCT
gra-919	2	22	.	.	PUNCT
gra-919	3	1	there	there	PRON
gra-919	3	2	is	be	VERB
gra-919	3	3	an	an	DET
gra-919	3	4	inverse	inverse	NOUN
gra-919	3	5	relationship	relationship	NOUN
gra-919	3	6	between	between	ADP
gra-919	3	7	the	the	DET
gra-919	3	8	incidence	incidence	NOUN
gra-919	3	9	of	of	ADP
gra-919	3	10	neonatal	neonatal	ADJ
gra-919	3	11	sepsis	sepsis	NOUN
gra-919	3	12	and	and	CCONJ
gra-919	3	13	birth	birth	NOUN
gra-919	3	14	weight(4,5	weight(4,5	NOUN
gra-919	3	15	)	)	PUNCT
gra-919	3	16	.	.	PUNCT
gra-919	4	1	the	the	DET
gra-919	4	2	world	world	PROPN
gra-919	4	3	health	health	PROPN
gra-919	4	4	organization	organization	NOUN
gra-919	4	5	currently	currently	ADV
gra-919	4	6	recommends	recommend	VERB
gra-919	4	7	ampicillin	ampicillin	NOUN
gra-919	4	8	or	or	CCONJ
gra-919	4	9	cloxacillin	cloxacillin	NOUN
gra-919	4	10	(	(	PUNCT
gra-919	4	11	if	if	SCONJ
gra-919	4	12	the	the	DET
gra-919	4	13	staphylococcal	staphylococcal	ADJ
gra-919	4	14	infection	infection	NOUN
gra-919	4	15	is	be	AUX
gra-919	4	16	suspected	suspect	VERB
gra-919	4	17	)	)	PUNCT
gra-919	4	18	and	and	CCONJ
gra-919	4	19	gentamicin	gentamicin	VERB
gra-919	4	20	for	for	ADP
gra-919	4	21	the	the	DET
gra-919	4	22	empiric	empiric	ADJ
gra-919	4	23	treatment	treatment	NOUN
gra-919	4	24	of	of	ADP
gra-919	4	25	suspected	suspect	VERB
gra-919	4	26	neonatal	neonatal	ADJ
gra-919	4	27	clinical	clinical	ADJ
gra-919	4	28	sepsis	sepsis	NOUN
gra-919	4	29	(	(	PUNCT
gra-919	4	30	6	6	NUM
gra-919	4	31	)	)	PUNCT
gra-919	4	32	.	.	PUNCT
gra-919	5	1	however	however	ADV
gra-919	5	2	,	,	PUNCT
gra-919	5	3	thirdgeneration	thirdgeneration	NOUN
gra-919	5	4	cephalosporins	cephalosporin	NOUN
gra-919	5	5	,	,	PUNCT
gra-919	5	6	particularly	particularly	ADV
gra-919	5	7	cefotaxime	cefotaxime	NOUN
gra-919	5	8	,	,	PUNCT
gra-919	5	9	are	be	AUX
gra-919	5	10	also	also	ADV
gra-919	5	11	commonly	commonly	ADV
gra-919	5	12	utilized	utilize	VERB
gra-919	5	13	.	.	PUNCT
gra-919	6	1	late	late	ADJ
gra-919	6	2	-	-	PUNCT
gra-919	6	3	onset	onset	NOUN
gra-919	6	4	neonatal	neonatal	ADJ
gra-919	6	5	sepsis	sepsis	NOUN
gra-919	6	6	is	be	AUX
gra-919	6	7	usually	usually	ADV
gra-919	6	8	caused	cause	VERB
gra-919	6	9	by	by	ADP
gra-919	6	10	neonatal	neonatal	ADJ
gra-919	6	11	intensive	intensive	ADJ
gra-919	6	12	care	care	NOUN
gra-919	6	13	units	unit	NOUN
gra-919	6	14	(	(	PUNCT
gra-919	6	15	nicus)-acquired	nicus)-acquired	ADJ
gra-919	6	16	pathogens	pathogen	NOUN
gra-919	6	17	and	and	CCONJ
gra-919	6	18	changes	change	NOUN
gra-919	6	19	in	in	ADP
gra-919	6	20	antimicrobial	antimicrobial	ADJ
gra-919	6	21	susceptibility	susceptibility	NOUN
gra-919	6	22	patterns	pattern	NOUN
gra-919	6	23	necessitate	necessitate	ADJ
gra-919	6	24	a	a	DET
gra-919	6	25	regular	regular	ADJ
gra-919	6	26	review	review	NOUN
gra-919	6	27	of	of	ADP
gra-919	6	28	antibiotics	antibiotic	NOUN
gra-919	6	29	regimen	regiman	NOUN
gra-919	6	30	.	.	PUNCT
gra-919	7	1	grampositive	grampositive	ADJ
gra-919	7	2	organisms	organism	NOUN
gra-919	7	3	,	,	PUNCT
gra-919	7	4	particularly	particularly	ADV
gra-919	7	5	coagulase	coagulase	ADJ
gra-919	7	6	-	-	PUNCT
gra-919	7	7	negative	negative	ADJ
gra-919	7	8	staphylococcus	staphylococcus	NOUN
gra-919	7	9	and	and	CCONJ
gra-919	7	10	group	group	NOUN
gra-919	7	11	b	b	PROPN
gra-919	7	12	streptococci	streptococci	NOUN
gra-919	7	13	,	,	PUNCT
gra-919	7	14	are	be	AUX
gra-919	7	15	major	major	ADJ
gra-919	7	16	causative	causative	ADJ
gra-919	7	17	agents	agent	NOUN
gra-919	7	18	of	of	ADP
gra-919	7	19	late	late	ADJ
gra-919	7	20	and	and	CCONJ
gra-919	7	21	early	early	ADJ
gra-919	7	22	-	-	PUNCT
gra-919	7	23	onset	onset	NOUN
gra-919	7	24	neo	neo	ADJ
gra-919	7	25	-	-	ADJ
gra-919	7	26	natal	natal	ADJ
gra-919	7	27	sepsis	sepsis	NOUN
gra-919	7	28	,	,	PUNCT
gra-919	7	29	respectively.(7,8	respectively.(7,8	NUM
gra-919	7	30	)	)	PUNCT
gra-919	7	31	.	.	PUNCT
gra-919	8	1	various	various	ADJ
gra-919	8	2	studies	study	NOUN
gra-919	8	3	done	do	VERB
gra-919	8	4	in	in	ADP
gra-919	8	5	different	different	ADJ
gra-919	8	6	nicus	nicus	NOUN
gra-919	8	7	showed	show	VERB
gra-919	8	8	that	that	SCONJ
gra-919	8	9	the	the	DET
gra-919	8	10	incidence	incidence	NOUN
gra-919	8	11	of	of	ADP
gra-919	8	12	infection	infection	NOUN
gra-919	8	13	was	be	AUX
gra-919	8	14	predominantly	predominantly	ADV
gra-919	8	15	with	with	ADP
gra-919	8	16	gram	gram	NOUN
gra-919	8	17	-	-	PUNCT
gra-919	8	18	positive	positive	ADJ
gra-919	8	19	microorganisms	microorganism	NOUN
gra-919	8	20	around	around	ADP
gra-919	8	21	60	60	NUM
gra-919	8	22	%	%	NOUN
gra-919	8	23	and	and	CCONJ
gra-919	8	24	coagulasenegative	coagulasenegative	ADJ
gra-919	8	25	staphylococcus	staphylococcus	NOUN
gra-919	8	26	was	be	AUX
gra-919	8	27	the	the	DET
gra-919	8	28	predominantly	predominantly	ADV
gra-919	8	29	isolated	isolate	VERB
gra-919	8	30	pathogen	pathogen	NOUN
gra-919	8	31	.	.	PUNCT
gra-919	9	1	they	they	PRON
gra-919	9	2	also	also	ADV
gra-919	9	3	reported	report	VERB
gra-919	9	4	that	that	SCONJ
gra-919	9	5	gram	gram	NOUN
gra-919	9	6	-	-	PUNCT
gra-919	9	7	negative	negative	ADJ
gra-919	9	8	microorganisms	microorganism	NOUN
gra-919	9	9	,	,	PUNCT
gra-919	9	10	mainly	mainly	ADV
gra-919	9	11	escherichia	escherichia	NOUN
gra-919	9	12	coli	coli	NOUN
gra-919	9	13	,	,	PUNCT
gra-919	9	14	klebsiella	klebsiella	PROPN
gra-919	9	15	sp	sp	PROPN
gra-919	9	16	.	.	PROPN
gra-919	9	17	,	,	PUNCT
gra-919	9	18	and	and	CCONJ
gra-919	9	19	pseudomonas	pseudomona	NOUN
gra-919	9	20	aeruginosa	aeruginosa	NOUN
gra-919	9	21	,	,	PUNCT
gra-919	9	22	accounted	account	VERB
gra-919	9	23	for	for	ADP
gra-919	9	24	38	38	NUM
gra-919	9	25	%	%	NOUN
gra-919	9	26	of	of	ADP
gra-919	9	27	isolated	isolated	ADJ
gra-919	9	28	organisms(9	organisms(9	NOUN
gra-919	9	29	)	)	PUNCT
gra-919	9	30	and	and	CCONJ
gra-919	9	31	over	over	ADP
gra-919	9	32	90	90	NUM
gra-919	9	33	%	%	NOUN
gra-919	9	34	of	of	ADP
gra-919	9	35	the	the	DET
gra-919	9	36	gram	gram	NOUN
gra-919	9	37	-	-	PUNCT
gra-919	9	38	negative	negative	ADJ
gra-919	9	39	organisms	organism	NOUN
gra-919	9	40	were	be	AUX
gra-919	9	41	susceptible	susceptible	ADJ
gra-919	9	42	to	to	ADP
gra-919	9	43	gentamicin	gentamicin	NOUN
gra-919	9	44	and	and	CCONJ
gra-919	9	45	amikacin(9	amikacin(9	NOUN
gra-919	9	46	)	)	PUNCT
gra-919	9	47	.	.	PUNCT
gra-919	10	1	the	the	DET
gra-919	10	2	united	united	PROPN
gra-919	10	3	kingdom	kingdom	PROPN
gra-919	10	4	's	's	PART
gra-919	10	5	health	health	PROPN
gra-919	10	6	protection	protection	PROPN
gra-919	10	7	agency	agency	NOUN
gra-919	10	8	's	's	PART
gra-919	10	9	national	national	ADJ
gra-919	10	10	bacteremia	bacteremia	NOUN
gra-919	10	11	surveillance	surveillance	NOUN
gra-919	10	12	also	also	ADV
gra-919	10	13	reported	report	VERB
gra-919	10	14	that	that	SCONJ
gra-919	10	15	over	over	ADP
gra-919	10	16	95	95	NUM
gra-919	10	17	%	%	NOUN
gra-919	10	18	of	of	ADP
gra-919	10	19	organisms	organism	NOUN
gra-919	10	20	causing	cause	VERB
gra-919	10	21	neonatal	neonatal	ADJ
gra-919	10	22	sepsis	sepsis	NOUN
gra-919	10	23	were	be	AUX
gra-919	10	24	susceptible	susceptible	ADJ
gra-919	10	25	to	to	ADP
gra-919	10	26	gentamicin	gentamicin	NOUN
gra-919	10	27	with	with	ADP
gra-919	10	28	either	either	CCONJ
gra-919	10	29	fucloxacillin	fucloxacillin	NOUN
gra-919	10	30	or	or	CCONJ
gra-919	10	31	amoxicillin	amoxicillin	PROPN
gra-919	10	32	and	and	CCONJ
gra-919	10	33	amoxicillin	amoxicillin	PROPN
gra-919	10	34	with	with	ADP
gra-919	10	35	cefotaxime(10	cefotaxime(10	ADJ
gra-919	10	36	)	)	PUNCT
gra-919	10	37	.	.	PUNCT
gra-919	11	1	due	due	ADP
gra-919	11	2	to	to	ADP
gra-919	11	3	the	the	DET
gra-919	11	4	difculties	difcultie	NOUN
gra-919	11	5	in	in	ADP
gra-919	11	6	a	a	DET
gra-919	11	7	prompt	prompt	ADJ
gra-919	11	8	diagnosis	diagnosis	NOUN
gra-919	11	9	of	of	ADP
gra-919	11	10	los	los	PROPN
gra-919	11	11	,	,	PUNCT
gra-919	11	12	losassociated	losassociate	VERB
gra-919	11	13	h	h	NOUN
gra-919	11	14	igh	igh	PROPN
gra-919	11	15	r	r	NOUN
gra-919	11	16	isk	isk	NOUN
gra-919	12	1	o	o	X
gra-919	12	2	f	f	X
gra-919	12	3	mor	mor	PROPN
gra-919	12	4	tal	tal	PROPN
gra-919	12	5	i	i	PROPN
gra-919	12	6	ty	ty	INTJ
gra-919	12	7	and	and	CCONJ
gra-919	12	8	longterm	longterm	VERB
gra-919	12	9	neurodevelopmental	neurodevelopmental	ADJ
gra-919	12	10	sequelae	sequelae	PROPN
gra-919	12	11	,	,	PUNCT
gra-919	12	12	the	the	DET
gra-919	12	13	symptoms	symptom	NOUN
gra-919	12	14	of	of	ADP
gra-919	12	15	neonatal	neonatal	ADJ
gra-919	12	16	sepsis	sepsis	NOUN
gra-919	12	17	being	be	AUX
gra-919	12	18	nonspecic	nonspecic	VERB
gra-919	12	19	,	,	PUNCT
gra-919	12	20	differentiating	differentiate	VERB
gra-919	12	21	between	between	ADP
gra-919	12	22	neonatal	neonatal	ADJ
gra-919	12	23	sepsis	sepsis	NOUN
gra-919	12	24	and	and	CCONJ
gra-919	12	25	the	the	DET
gra-919	12	26	symptoms	symptom	NOUN
gra-919	12	27	of	of	ADP
gra-919	12	28	prematurity	prematurity	NOUN
gra-919	12	29	is	be	AUX
gra-919	12	30	often	often	ADV
gra-919	12	31	difcult	difcult	ADJ
gra-919	12	32	,	,	PUNCT
gra-919	12	33	empirical	empirical	ADJ
gra-919	12	34	antibiotic	antibiotic	ADJ
gra-919	12	35	treatment	treatment	NOUN
gra-919	12	36	is	be	AUX
gra-919	12	37	initiated	initiate	VERB
gra-919	12	38	on	on	ADP
gra-919	12	39	suspicion	suspicion	NOUN
gra-919	12	40	of	of	ADP
gra-919	12	41	los	los	PROPN
gra-919	12	42	.	.	PUNCT
gra-919	13	1	neonatologists	neonatologist	NOUN
gra-919	13	2	prescribe	prescribe	VERB
gra-919	13	3	broad	broad	ADJ
gra-919	13	4	-	-	PUNCT
gra-919	13	5	spectrum	spectrum	NOUN
gra-919	13	6	antibiotics	antibiotic	NOUN
gra-919	13	7	under	under	ADP
gra-919	13	8	the	the	DET
gra-919	13	9	assumption	assumption	NOUN
gra-919	13	10	that	that	SCONJ
gra-919	13	11	neonatal	neonatal	ADJ
gra-919	13	12	sepsis	sepsis	NOUN
gra-919	13	13	exists	exist	VERB
gra-919	13	14	,	,	PUNCT
gra-919	13	15	even	even	ADV
gra-919	13	16	after	after	ADP
gra-919	13	17	a	a	DET
gra-919	13	18	negative	negative	ADJ
gra-919	13	19	result	result	NOUN
gra-919	13	20	on	on	ADP
gra-919	13	21	initial	initial	ADJ
gra-919	13	22	blood	blood	NOUN
gra-919	13	23	culture	culture	NOUN
gra-919	13	24	.	.	PUNCT
gra-919	14	1	as	as	SCONJ
gra-919	14	2	the	the	DET
gra-919	14	3	evidence	evidence	NOUN
gra-919	14	4	for	for	ADP
gra-919	14	5	the	the	DET
gra-919	14	6	most	most	ADV
gra-919	14	7	suitable	suitable	ADJ
gra-919	14	8	empirical	empirical	ADJ
gra-919	14	9	antibiotics	antibiotic	NOUN
gra-919	14	10	for	for	ADP
gra-919	14	11	late	late	ADJ
gra-919	14	12	-	-	PUNCT
gra-919	14	13	onset	onset	NOUN
gra-919	14	14	neonatal	neonatal	ADJ
gra-919	14	15	sepsis	sepsis	NOUN
gra-919	14	16	is	be	AUX
gra-919	14	17	lacking	lack	VERB
gra-919	14	18	;	;	PUNCT
gra-919	14	19	therefore	therefore	ADV
gra-919	14	20	,	,	PUNCT
gra-919	14	21	there	there	PRON
gra-919	14	22	are	be	VERB
gra-919	14	23	no	no	DET
gra-919	14	24	consensus	consensus	NOUN
gra-919	14	25	guidelines	guideline	NOUN
gra-919	14	26	on	on	ADP
gra-919	14	27	an	an	DET
gra-919	14	28	antibiotic	antibiotic	ADJ
gra-919	14	29	regimen	regiman	NOUN
gra-919	14	30	.	.	PUNCT
gra-919	15	1	consequently	consequently	ADV
gra-919	15	2	,	,	PUNCT
gra-919	15	3	the	the	DET
gra-919	15	4	empiric	empiric	ADJ
gra-919	15	5	treatment	treatment	NOUN
gra-919	15	6	of	of	ADP
gra-919	15	7	lateonset	lateonset	NOUN
gra-919	15	8	neonatal	neonatal	ADJ
gra-919	15	9	sepsis	sepsis	NOUN
gra-919	15	10	differs	differ	VERB
gra-919	15	11	between	between	ADP
gra-919	15	12	nicus	nicus	PROPN
gra-919	15	13	and	and	CCONJ
gra-919	15	14	among	among	ADP
gra-919	15	15	countries	country	NOUN
gra-919	15	16	.	.	PUNCT
gra-919	16	1	in	in	ADP
gra-919	16	2	our	our	PRON
gra-919	16	3	unit	unit	NOUN
gra-919	16	4	,	,	PUNCT
gra-919	16	5	cloxacillin	cloxacillin	NOUN
gra-919	16	6	and	and	CCONJ
gra-919	16	7	amikacin	amikacin	PROPN
gra-919	16	8	are	be	AUX
gra-919	16	9	the	the	DET
gra-919	16	10	commonly	commonly	ADV
gra-919	16	11	used	use	VERB
gra-919	16	12	antibiotics	antibiotic	NOUN
gra-919	16	13	for	for	ADP
gra-919	16	14	the	the	DET
gra-919	16	15	empiric	empiric	ADJ
gra-919	16	16	treatment	treatment	NOUN
gra-919	16	17	of	of	ADP
gra-919	16	18	lateonset	lateonset	NOUN
gra-919	16	19	sepsis	sepsis	NOUN
gra-919	16	20	.	.	PUNCT
gra-919	17	1	however	however	ADV
gra-919	17	2	,	,	PUNCT
gra-919	17	3	cefotaxime	cefotaxime	NOUN
gra-919	17	4	with	with	ADP
gra-919	17	5	ampicillin	ampicillin	NOUN
gra-919	17	6	is	be	AUX
gra-919	17	7	also	also	ADV
gra-919	17	8	used	use	VERB
gra-919	17	9	occasionally	occasionally	ADV
gra-919	17	10	.	.	PUNCT
gra-919	18	1	on	on	ADP
gra-919	18	2	account	account	NOUN
gra-919	18	3	of	of	ADP
gra-919	18	4	the	the	DET
gra-919	18	5	increased	increase	VERB
gra-919	18	6	survival	survival	NOUN
gra-919	18	7	of	of	ADP
gra-919	18	8	preterm	preterm	NOUN
gra-919	18	9	neonates	neonate	NOUN
gra-919	18	10	and	and	CCONJ
gra-919	18	11	their	their	PRON
gra-919	18	12	more	more	ADV
gra-919	18	13	extended	extended	ADJ
gra-919	18	14	hospitalization	hospitalization	NOUN
gra-919	18	15	,	,	PUNCT
gra-919	18	16	late	late	ADJ
gra-919	18	17	-	-	PUNCT
gra-919	18	18	onset	onset	NOUN
gra-919	18	19	sepsis	sepsis	NOUN
gra-919	18	20	will	will	AUX
gra-919	18	21	continue	continue	VERB
gra-919	18	22	to	to	PART
gra-919	18	23	be	be	AUX
gra-919	18	24	a	a	DET
gra-919	18	25	challenge	challenge	NOUN
gra-919	18	26	.	.	PUNCT
gra-919	19	1	in	in	ADP
gra-919	19	2	this	this	DET
gra-919	19	3	study	study	NOUN
gra-919	19	4	,	,	PUNCT
gra-919	19	5	we	we	PRON
gra-919	19	6	c	c	VERB
gra-919	19	7	o	o	NOUN
gra-919	20	1	m	m	VERB
gra-919	20	2	p	p	X
gra-919	21	1	a	a	DET
gra-919	21	2	r	r	NOUN
gra-919	21	3	e	e	NOUN
gra-919	21	4	d	d	NOUN
gra-919	21	5	t	t	NOUN
gra-919	21	6	h	h	NOUN
gra-919	21	7	e	e	PROPN
gra-919	22	1	d	d	NOUN
gra-919	22	2	i	i	PRON
gra-919	22	3	f	f	NOUN
gra-919	22	4	f	f	NOUN
gra-919	22	5	e	e	NOUN
gra-919	22	6	r	r	NOUN
gra-919	22	7	e	e	NOUN
gra-919	22	8	n	n	NOUN
gra-919	22	9	c	c	NOUN
gra-919	22	10	e	e	NOUN
gra-919	22	11	i	i	PRON
gra-919	22	12	n	n	VERB
gra-919	22	13	m	m	VERB
gra-919	22	14	o	o	NOUN
gra-919	22	15	r	r	NOUN
gra-919	22	16	t	t	NOUN
gra-919	22	17	a	a	DET
gra-919	22	18	l	l	NOUN
gra-919	23	1	i	i	PRON
gra-919	23	2	t	t	VERB
gra-919	23	3	y	y	PROPN
gra-919	23	4	b	b	PROPN
gra-919	23	5	e	e	PROPN
gra-919	23	6	t	t	PROPN
gra-919	23	7	w	w	PROPN
gra-919	23	8	e	e	PROPN
gra-919	23	9	e	e	PROPN
gra-919	23	10	n	n	PRON
gra-919	23	11	cloxacillin	cloxacillin	NOUN
gra-919	23	12	–	–	PUNCT
gra-919	23	13	amikacin	amikacin	PROPN
gra-919	23	14	and	and	CCONJ
gra-919	23	15	cefotaxime	cefotaxime	NOUN
gra-919	23	16	–	–	PUNCT
gra-919	23	17	ampicillin	ampicillin	NOUN
gra-919	23	18	regimens	regimen	NOUN
gra-919	23	19	in	in	ADP
gra-919	23	20	neonates	neonate	NOUN
gra-919	23	21	with	with	ADP
gra-919	23	22	neonatal	neonatal	ADJ
gra-919	23	23	sepsis	sepsis	NOUN
gra-919	23	24	.	.	PUNCT
gra-919	24	1	we	we	PRON
gra-919	24	2	hypothesize	hypothesize	VERB
gra-919	24	3	that	that	SCONJ
gra-919	24	4	on	on	ADP
gra-919	24	5	account	account	NOUN
gra-919	24	6	of	of	ADP
gra-919	24	7	better	well	ADJ
gra-919	24	8	bacterial	bacterial	ADJ
gra-919	24	9	susceptibility	susceptibility	NOUN
gra-919	24	10	to	to	ADP
gra-919	24	11	amikacin	amikacin	PROPN
gra-919	24	12	,	,	PUNCT
gra-919	24	13	empirical	empirical	ADJ
gra-919	24	14	treatment	treatment	NOUN
gra-919	24	15	of	of	ADP
gra-919	24	16	very	very	ADV
gra-919	24	17	low	low	ADJ
gra-919	24	18	birth	birth	NOUN
gra-919	24	19	weight	weight	NOUN
gra-919	24	20	(	(	PUNCT
gra-919	24	21	vlbw	vlbw	NOUN
gra-919	24	22	)	)	PUNCT
gra-919	24	23	neonates	neonate	NOUN
gra-919	24	24	with	with	ADP
gra-919	24	25	an	an	DET
gra-919	24	26	amikacin	amikacin	PROPN
gra-919	24	27	-	-	PUNCT
gra-919	24	28	based	base	VERB
gra-919	24	29	regimen	regiman	NOUN
gra-919	24	30	would	would	AUX
gra-919	24	31	result	result	VERB
gra-919	24	32	in	in	ADP
gra-919	24	33	lower	low	ADJ
gra-919	24	34	mortality	mortality	NOUN
gra-919	24	35	.	.	PUNCT
gra-919	25	1	methods	method	NOUN
gra-919	25	2	:	:	PUNCT
gra-919	25	3	this	this	DET
gra-919	25	4	study	study	NOUN
gra-919	25	5	was	be	AUX
gra-919	25	6	carried	carry	VERB
gra-919	25	7	out	out	ADP
gra-919	25	8	in	in	ADP
gra-919	25	9	the	the	DET
gra-919	25	10	nicu	nicu	NOUN
gra-919	25	11	of	of	ADP
gra-919	25	12	gb	gb	PROPN
gra-919	25	13	pant	pant	NOUN
gra-919	25	14	hospital	hospital	NOUN
gra-919	25	15	,	,	PUNCT
gra-919	25	16	a	a	DET
gra-919	25	17	tertiary	tertiary	ADJ
gra-919	25	18	hospital	hospital	NOUN
gra-919	25	19	in	in	ADP
gra-919	25	20	kashmir	kashmir	PROPN
gra-919	25	21	.	.	PUNCT
gra-919	26	1	we	we	PRON
gra-919	26	2	retrieved	retrieve	VERB
gra-919	26	3	the	the	DET
gra-919	26	4	medical	medical	ADJ
gra-919	26	5	records	record	NOUN
gra-919	26	6	of	of	ADP
gra-919	26	7	consecutively	consecutively	ADV
gra-919	26	8	admitted	admit	VERB
gra-919	26	9	vlbw	vlbw	NOUN
gra-919	26	10	neonates	neonate	NOUN
gra-919	26	11	with	with	ADP
gra-919	26	12	rst	rst	PROPN
gra-919	26	13	episodes	episode	NOUN
gra-919	26	14	of	of	ADP
gra-919	26	15	late	late	ADJ
gra-919	26	16	-	-	PUNCT
gra-919	26	17	onset	onset	NOUN
gra-919	26	18	sepsis	sepsis	NOUN
gra-919	26	19	between	between	ADP
gra-919	26	20	march	march	PROPN
gra-919	26	21	2014	2014	NUM
gra-919	26	22	and	and	CCONJ
gra-919	26	23	april	april	PROPN
gra-919	26	24	2016	2016	NUM
gra-919	26	25	.	.	PUNCT
gra-919	27	1	only	only	ADV
gra-919	27	2	vlbw	vlbw	NOUN
gra-919	27	3	neonates	neonate	NOUN
gra-919	27	4	(	(	PUNCT
gra-919	27	5	<	<	X
gra-919	27	6	1,500	1,500	NUM
gra-919	27	7	g	g	NOUN
gra-919	27	8	)	)	PUNCT
gra-919	27	9	with	with	ADP
gra-919	27	10	suspected	suspect	VERB
gra-919	27	11	late	late	ADJ
gra-919	27	12	-	-	PUNCT
gra-919	27	13	onset	onset	NOUN
gra-919	27	14	neonatal	neonatal	ADJ
gra-919	27	15	infection	infection	NOUN
gra-919	27	16	were	be	AUX
gra-919	27	17	eligible	eligible	ADJ
gra-919	27	18	for	for	ADP
gra-919	27	19	inclusion	inclusion	NOUN
gra-919	27	20	.	.	PUNCT
gra-919	28	1	we	we	PRON
gra-919	28	2	dened	dene	VERB
gra-919	28	3	late	late	ADJ
gra-919	28	4	-	-	PUNCT
gra-919	28	5	onset	onset	NOUN
gra-919	28	6	sepsis	sepsis	NOUN
gra-919	28	7	as	as	ADP
gra-919	28	8	sepsis	sepsis	NOUN
gra-919	28	9	occurring	occur	VERB
gra-919	28	10	after	after	ADP
gra-919	28	11	72	72	NUM
gra-919	28	12	hours	hour	NOUN
gra-919	28	13	of	of	ADP
gra-919	28	14	birth	birth	NOUN
gra-919	28	15	.	.	PUNCT
gra-919	29	1	demographic	demographic	ADJ
gra-919	29	2	data	datum	NOUN
gra-919	29	3	including	include	VERB
gra-919	29	4	birth	birth	NOUN
gra-919	29	5	weight	weight	NOUN
gra-919	29	6	,	,	PUNCT
gra-919	29	7	gestational	gestational	ADJ
gra-919	29	8	age	age	NOUN
gra-919	29	9	,	,	PUNCT
gra-919	29	10	and	and	CCONJ
gra-919	29	11	sex	sex	NOUN
gra-919	29	12	were	be	AUX
gra-919	29	13	extracted	extract	VERB
gra-919	29	14	,	,	PUNCT
gra-919	29	15	in	in	ADP
gra-919	29	16	addition	addition	NOUN
gra-919	29	17	to	to	ADP
gra-919	29	18	data	datum	NOUN
gra-919	29	19	regarding	regard	VERB
gra-919	29	20	comorbid	comorbid	NOUN
gra-919	29	21	conditions	condition	NOUN
gra-919	29	22	such	such	ADJ
gra-919	29	23	as	as	ADP
gra-919	29	24	intraventricular	intraventricular	ADJ
gra-919	29	25	hemorrhage	hemorrhage	NOUN
gra-919	29	26	,	,	PUNCT
gra-919	29	27	necrotizing	necrotizing	NOUN
gra-919	29	28	enterocolitis	enterocolitis	NOUN
gra-919	29	29	,	,	PUNCT
gra-919	29	30	hypoxic	hypoxic	ADJ
gra-919	29	31	-	-	PUNCT
gra-919	29	32	ischemic	ischemic	ADJ
gra-919	29	33	encephalopathy	encephalopathy	NOUN
gra-919	29	34	,	,	PUNCT
gra-919	29	35	patent	patent	NOUN
gra-919	29	36	ductus	ductus	NOUN
gra-919	29	37	arteriosus	arteriosus	NOUN
gra-919	29	38	,	,	PUNCT
gra-919	29	39	and	and	CCONJ
gra-919	29	40	periven	periven	ADJ
gra-919	29	41	-	-	PUNCT
gra-919	29	42	tricular	tricular	ADJ
gra-919	29	43	leukomalacia	leukomalacia	NOUN
gra-919	29	44	.	.	PUNCT
gra-919	30	1	we	we	PRON
gra-919	30	2	also	also	ADV
gra-919	30	3	extracted	extract	VERB
gra-919	30	4	data	datum	NOUN
gra-919	30	5	regarding	regard	VERB
gra-919	30	6	sedative	sedative	NOUN
gra-919	30	7	and	and	CCONJ
gra-919	30	8	inotropic	inotropic	NOUN
gra-919	30	9	drug	drug	NOUN
gra-919	30	10	treatment	treatment	NOUN
gra-919	30	11	during	during	ADP
gra-919	30	12	hospitalization	hospitalization	NOUN
gra-919	30	13	;	;	PUNCT
gra-919	30	14	invasive	invasive	ADJ
gra-919	30	15	respiratory	respiratory	ADJ
gra-919	30	16	support	support	NOUN
gra-919	30	17	(	(	PUNCT
gra-919	30	18	ie	ie	X
gra-919	30	19	,	,	PUNCT
gra-919	30	20	intubation	intubation	NOUN
gra-919	30	21	)	)	PUNCT
gra-919	30	22	during	during	ADP
gra-919	30	23	hospitalization	hospitalization	NOUN
gra-919	30	24	;	;	PUNCT
gra-919	30	25	the	the	DET
gra-919	30	26	types	type	NOUN
gra-919	30	27	of	of	ADP
gra-919	30	28	antibiotics	antibiotic	NOUN
gra-919	30	29	received	receive	VERB
gra-919	30	30	;	;	PUNCT
gra-919	30	31	the	the	DET
gra-919	30	32	number	number	NOUN
gra-919	30	33	of	of	ADP
gra-919	30	34	courses	course	NOUN
gra-919	30	35	and	and	CCONJ
gra-919	30	36	the	the	DET
gra-919	30	37	duration	duration	NOUN
gra-919	30	38	of	of	ADP
gra-919	30	39	antibiotics	antibiotic	NOUN
gra-919	30	40	;	;	PUNCT
gra-919	30	41	and	and	CCONJ
gra-919	30	42	the	the	DET
gra-919	30	43	number	number	NOUN
gra-919	30	44	of	of	ADP
gra-919	30	45	days	day	NOUN
gra-919	30	46	of	of	ADP
gra-919	30	47	hospitalization	hospitalization	NOUN
gra-919	30	48	and	and	CCONJ
gra-919	30	49	the	the	DET
gra-919	30	50	out	out	ADV
gra-919	30	51	-	-	PUNCT
gra-919	30	52	come	come	NOUN
gra-919	30	53	of	of	ADP
gra-919	30	54	treatment	treatment	NOUN
gra-919	30	55	.	.	PUNCT
gra-919	31	1	study	study	NOUN
gra-919	31	2	design	design	NOUN
gra-919	31	3	it	it	PRON
gra-919	31	4	is	be	AUX
gra-919	31	5	a	a	DET
gra-919	31	6	retrospective	retrospective	ADJ
gra-919	31	7	cohort	cohort	NOUN
gra-919	31	8	study	study	NOUN
gra-919	31	9	and	and	CCONJ
gra-919	31	10	identied	identied	PROPN
gra-919	31	11	2	2	NUM
gra-919	31	12	treatment	treatment	NOUN
gra-919	31	13	cohorts	cohort	NOUN
gra-919	31	14	.	.	PUNCT
gra-919	32	1	the	the	DET
gra-919	32	2	primary	primary	ADJ
gra-919	32	3	cohort	cohort	NOUN
gra-919	32	4	was	be	AUX
gra-919	32	5	neonates	neonate	NOUN
gra-919	32	6	receiving	receive	VERB
gra-919	32	7	empiric	empiric	ADJ
gra-919	32	8	comparison	comparison	NOUN
gra-919	32	9	between	between	ADP
gra-919	32	10	two	two	NUM
gra-919	32	11	commonly	commonly	ADV
gra-919	32	12	used	use	VERB
gra-919	32	13	emperic	emperic	ADJ
gra-919	32	14	antibiotoc	antibiotoc	ADJ
gra-919	32	15	regimens	regimen	NOUN
gra-919	32	16	in	in	ADP
gra-919	32	17	neonatal	neonatal	ADJ
gra-919	32	18	sepsis	sepsis	NOUN
gra-919	32	19	original	original	ADJ
gra-919	32	20	research	research	NOUN
gra-919	32	21	paper	paper	NOUN
gra-919	32	22	sheikh	sheikh	NOUN
gra-919	32	23	quyoom	quyoom	PROPN
gra-919	32	24	hussain	hussain	PROPN
gra-919	32	25	registrar	registrar	PROPN
gra-919	32	26	,	,	PUNCT
gra-919	32	27	department	department	NOUN
gra-919	32	28	of	of	ADP
gra-919	32	29	paediatrics	paediatric	NOUN
gra-919	32	30	,	,	PUNCT
gra-919	32	31	gb	gb	ADP
gra-919	32	32	pant	pant	NOUN
gra-919	32	33	hospital	hospital	NOUN
gra-919	32	34	,	,	PUNCT
gra-919	32	35	government	government	NOUN
gra-919	32	36	medical	medical	PROPN
gra-919	32	37	college	college	PROPN
gra-919	32	38	srinagar	srinagar	PROPN
gra-919	32	39	,	,	PUNCT
gra-919	32	40	india	india	PROPN
gra-919	32	41	.	.	PUNCT
gra-919	33	1	x	x	PUNCT
gra-919	33	2	79gjra	79gjra	NUM
gra-919	33	3	global	global	ADJ
gra-919	33	4	journal	journal	NOUN
gra-919	33	5	for	for	ADP
gra-919	33	6	research	research	NOUN
gra-919	33	7	analysis	analysis	NOUN
gra-919	33	8	medical	medical	ADJ
gra-919	33	9	science	science	NOUN
gra-919	33	10	background	background	NOUN
gra-919	33	11	:	:	PUNCT
gra-919	33	12	neonatal	neonatal	ADJ
gra-919	33	13	sepsis	sepsis	NOUN
gra-919	33	14	remains	remain	VERB
gra-919	33	15	a	a	DET
gra-919	33	16	major	major	ADJ
gra-919	33	17	cause	cause	NOUN
gra-919	33	18	of	of	ADP
gra-919	33	19	morbidity	morbidity	NOUN
gra-919	33	20	and	and	CCONJ
gra-919	33	21	mortality	mortality	NOUN
gra-919	33	22	and	and	CCONJ
gra-919	33	23	warrants	warrant	NOUN
gra-919	33	24	the	the	DET
gra-919	33	25	immediate	immediate	ADJ
gra-919	33	26	start	start	NOUN
gra-919	33	27	of	of	ADP
gra-919	33	28	appropriate	appropriate	ADJ
gra-919	33	29	empiric	empiric	ADJ
gra-919	33	30	treatment	treatment	NOUN
gra-919	33	31	.	.	PUNCT
gra-919	34	1	thus	thus	ADV
gra-919	34	2	,	,	PUNCT
gra-919	34	3	this	this	DET
gra-919	34	4	study	study	NOUN
gra-919	34	5	compared	compare	VERB
gra-919	34	6	the	the	DET
gra-919	34	7	effectiveness	effectiveness	NOUN
gra-919	34	8	of	of	ADP
gra-919	34	9	the	the	DET
gra-919	34	10	2	2	NUM
gra-919	34	11	antibiotic	antibiotic	ADJ
gra-919	34	12	regimens	regimen	NOUN
gra-919	34	13	(	(	PUNCT
gra-919	34	14	cloxacillin	cloxacillin	NOUN
gra-919	34	15	–	–	PUNCT
gra-919	34	16	amikacin	amikacin	PROPN
gra-919	34	17	or	or	CCONJ
gra-919	34	18	cefotaxime	cefotaxime	NOUN
gra-919	34	19	–	–	PUNCT
gra-919	34	20	ampicillin	ampicillin	NOUN
gra-919	34	21	)	)	PUNCT
gra-919	34	22	among	among	ADP
gra-919	34	23	neonates	neonate	NOUN
gra-919	34	24	with	with	ADP
gra-919	34	25	late	late	ADJ
gra-919	34	26	-	-	PUNCT
gra-919	34	27	onset	onset	NOUN
gra-919	34	28	neonatal	neonatal	ADJ
gra-919	34	29	sepsis	sepsis	NOUN
gra-919	34	30	.	.	PUNCT
gra-919	35	1	methods	method	NOUN
gra-919	35	2	:	:	PUNCT
gra-919	35	3	we	we	PRON
gra-919	35	4	conducted	conduct	VERB
gra-919	35	5	a	a	DET
gra-919	35	6	retrospective	retrospective	ADJ
gra-919	35	7	cohort	cohort	NOUN
gra-919	35	8	study	study	NOUN
gra-919	35	9	comparing	compare	VERB
gra-919	35	10	mortality	mortality	NOUN
gra-919	35	11	between	between	ADP
gra-919	35	12	2	2	NUM
gra-919	35	13	treatment	treatment	NOUN
gra-919	35	14	cohorts	cohort	NOUN
gra-919	35	15	of	of	ADP
gra-919	35	16	very	very	ADV
gra-919	35	17	low	low	ADJ
gra-919	35	18	birth	birth	NOUN
gra-919	35	19	weight	weight	NOUN
gra-919	35	20	neonates	neonate	NOUN
gra-919	35	21	with	with	ADP
gra-919	35	22	late	late	ADJ
gra-919	35	23	-	-	PUNCT
gra-919	35	24	onset	onset	NOUN
gra-919	35	25	sepsis	sepsis	NOUN
gra-919	35	26	,	,	PUNCT
gra-919	35	27	who	who	PRON
gra-919	35	28	had	have	AUX
gra-919	35	29	received	receive	VERB
gra-919	35	30	amikacin	amikacin	PROPN
gra-919	35	31	–	–	PUNCT
gra-919	35	32	cloxacillin	cloxacillin	NOUN
gra-919	35	33	or	or	CCONJ
gra-919	35	34	cefotaxime	cefotaxime	NOUN
gra-919	35	35	–	–	PUNCT
gra-919	35	36	ampicillin	ampicillin	NOUN
gra-919	35	37	between	between	ADP
gra-919	35	38	march	march	PROPN
gra-919	35	39	2014	2014	NUM
gra-919	35	40	and	and	CCONJ
gra-919	35	41	april	april	PROPN
gra-919	35	42	2016	2016	NUM
gra-919	35	43	.	.	PUNCT
gra-919	36	1	32	32	NUM
gra-919	36	2	neonates	neonate	NOUN
gra-919	36	3	were	be	AUX
gra-919	36	4	selected	select	VERB
gra-919	36	5	in	in	ADP
gra-919	36	6	each	each	DET
gra-919	36	7	group	group	NOUN
gra-919	36	8	after	after	ADP
gra-919	36	9	proper	proper	ADJ
gra-919	36	10	matching	matching	NOUN
gra-919	36	11	.	.	PUNCT
gra-919	37	1	results	result	NOUN
gra-919	37	2	:	:	PUNCT
gra-919	37	3	we	we	PRON
gra-919	37	4	identied	identied	PROPN
gra-919	37	5	a	a	DET
gra-919	37	6	total	total	NOUN
gra-919	37	7	of	of	ADP
gra-919	37	8	150	150	NUM
gra-919	37	9	neonates	neonate	NOUN
gra-919	37	10	from	from	ADP
gra-919	37	11	the	the	DET
gra-919	37	12	hospital	hospital	NOUN
gra-919	37	13	's	's	PART
gra-919	37	14	record	record	NOUN
gra-919	37	15	.	.	PUNCT
gra-919	38	1	we	we	PRON
gra-919	38	2	included	include	VERB
gra-919	38	3	32	32	NUM
gra-919	38	4	neonates	neonate	NOUN
gra-919	38	5	each	each	PRON
gra-919	38	6	in	in	ADP
gra-919	38	7	the	the	DET
gra-919	38	8	amikacin	amikacin	PROPN
gra-919	38	9	–	–	PUNCT
gra-919	38	10	cloxacillin	cloxacillin	NOUN
gra-919	38	11	and	and	CCONJ
gra-919	38	12	cefotaxime	cefotaxime	NOUN
gra-919	38	13	–	–	PUNCT
gra-919	38	14	ampicillin	ampicillin	NOUN
gra-919	38	15	groups	group	NOUN
gra-919	38	16	.	.	PUNCT
gra-919	39	1	intraventricular	intraventricular	ADJ
gra-919	39	2	hemorrhage	hemorrhage	NOUN
gra-919	39	3	,	,	PUNCT
gra-919	39	4	necrotizing	necrotizing	NOUN
gra-919	39	5	enterocolitis	enterocolitis	NOUN
gra-919	39	6	,	,	PUNCT
gra-919	39	7	birth	birth	NOUN
gra-919	39	8	weight	weight	NOUN
gra-919	39	9	,	,	PUNCT
gra-919	39	10	and	and	CCONJ
gra-919	39	11	gestational	gestational	ADJ
gra-919	39	12	age	age	NOUN
gra-919	39	13	were	be	AUX
gra-919	39	14	signicantly	signicantly	ADV
gra-919	39	15	associated	associate	VERB
gra-919	39	16	with	with	ADP
gra-919	39	17	mortality	mortality	NOUN
gra-919	39	18	(	(	PUNCT
gra-919	39	19	p	p	X
gra-919	39	20	<	<	X
gra-919	39	21	0.05	0.05	NUM
gra-919	39	22	)	)	PUNCT
gra-919	39	23	.	.	PUNCT
gra-919	40	1	the	the	DET
gra-919	40	2	risk	risk	NOUN
gra-919	40	3	of	of	ADP
gra-919	40	4	mortality	mortality	NOUN
gra-919	40	5	was	be	AUX
gra-919	40	6	signicantly	signicantly	ADV
gra-919	40	7	higher	high	ADJ
gra-919	40	8	in	in	ADP
gra-919	40	9	neonates	neonate	NOUN
gra-919	40	10	receiving	receive	VERB
gra-919	40	11	empiric	empiric	ADJ
gra-919	40	12	cefotaxime	cefotaxime	NOUN
gra-919	40	13	and	and	CCONJ
gra-919	40	14	ampicillin	ampicillin	NOUN
gra-919	40	15	than	than	ADP
gra-919	40	16	those	those	PRON
gra-919	40	17	receiving	receive	VERB
gra-919	40	18	amikacin	amikacin	PROPN
gra-919	40	19	and	and	CCONJ
gra-919	40	20	cloxacillin	cloxacillin	NOUN
gra-919	40	21	.	.	PUNCT
gra-919	41	1	conclusions	conclusion	NOUN
gra-919	41	2	:	:	PUNCT
gra-919	41	3	in	in	ADP
gra-919	41	4	our	our	PRON
gra-919	41	5	center	center	NOUN
gra-919	41	6	,	,	PUNCT
gra-919	41	7	amikacin	amikacin	PROPN
gra-919	41	8	–	–	PUNCT
gra-919	41	9	cloxacillin	cloxacillin	NOUN
gra-919	41	10	combination	combination	NOUN
gra-919	41	11	therapy	therapy	NOUN
gra-919	41	12	was	be	AUX
gra-919	41	13	associated	associate	VERB
gra-919	41	14	with	with	ADP
gra-919	41	15	lower	low	ADJ
gra-919	41	16	mortality	mortality	NOUN
gra-919	41	17	in	in	ADP
gra-919	41	18	very	very	ADV
gra-919	41	19	low	low	ADJ
gra-919	41	20	birth	birth	NOUN
gra-919	41	21	weight	weight	NOUN
gra-919	41	22	neonates	neonate	NOUN
gra-919	41	23	with	with	ADP
gra-919	41	24	late	late	ADJ
gra-919	41	25	-	-	PUNCT
gra-919	41	26	onset	onset	NOUN
gra-919	41	27	sepsis	sepsis	NOUN
gra-919	41	28	compared	compare	VERB
gra-919	41	29	with	with	ADP
gra-919	41	30	cefotaxime	cefotaxime	NOUN
gra-919	41	31	–	–	PUNCT
gra-919	41	32	ampicillin	ampicillin	NOUN
gra-919	41	33	therapy	therapy	NOUN
gra-919	41	34	.	.	PUNCT
gra-919	42	1	abstract	abstract	ADJ
gra-919	42	2	keywords	keyword	NOUN
gra-919	42	3	:	:	PUNCT
gra-919	42	4	juvera	juvera	PROPN
gra-919	42	5	gul	gul	PROPN
gra-919	42	6	wani	wani	PROPN
gra-919	42	7	*	*	PUNCT
gra-919	42	8	registrar	registrar	PROPN
gra-919	42	9	,	,	PUNCT
gra-919	42	10	department	department	NOUN
gra-919	42	11	of	of	ADP
gra-919	42	12	gynecology	gynecology	NOUN
gra-919	42	13	and	and	CCONJ
gra-919	42	14	obstetrics	obstetric	NOUN
gra-919	42	15	,	,	PUNCT
gra-919	42	16	lal	lal	PROPN
gra-919	42	17	ded	ded	PROPN
gra-919	42	18	hospital	hospital	PROPN
gra-919	42	19	srinagar	srinagar	PROPN
gra-919	42	20	,	,	PUNCT
gra-919	42	21	india	india	PROPN
gra-919	42	22	.	.	PUNCT
gra-919	43	1	*	*	PUNCT
gra-919	43	2	corresponding	correspond	VERB
gra-919	43	3	author	author	NOUN
gra-919	43	4	roshi	roshi	PROPN
gra-919	43	5	baghat	baghat	PROPN
gra-919	43	6	registrar	registrar	PROPN
gra-919	43	7	,	,	PUNCT
gra-919	43	8	department	department	NOUN
gra-919	43	9	of	of	ADP
gra-919	43	10	paediatrics	paediatric	NOUN
gra-919	43	11	,	,	PUNCT
gra-919	43	12	smgs	smgs	NOUN
gra-919	43	13	hospital	hospital	NOUN
gra-919	43	14	,	,	PUNCT
gra-919	43	15	government	government	NOUN
gra-919	43	16	medical	medical	PROPN
gra-919	43	17	college	college	PROPN
gra-919	43	18	jammu	jammu	PROPN
gra-919	43	19	,	,	PUNCT
gra-919	43	20	india	india	PROPN
gra-919	43	21	volume-8	volume-8	PROPN
gra-919	43	22	,	,	PUNCT
gra-919	43	23	issue-12	issue-12	NOUN
gra-919	43	24	,	,	PUNCT
gra-919	43	25	december-2019	december-2019	ADJ
gra-919	43	26	•	•	NUM
gra-919	43	27	print	print	NOUN
gra-919	43	28	issn	issn	PROPN
gra-919	43	29	no	no	NOUN
gra-919	43	30	.	.	PROPN
gra-919	43	31	2277	2277	NUM
gra-919	43	32	8160	8160	NUM
gra-919	43	33	•	•	NOUN
gra-919	43	34	doi	doi	NOUN
gra-919	43	35	:	:	PUNCT
gra-919	43	36	10.36106	10.36106	NUM
gra-919	43	37	/	/	SYM
gra-919	43	38	gjra	gjra	NOUN
gra-919	43	39	80	80	NUM
gra-919	43	40	x	x	NOUN
gra-919	43	41	gjra	gjra	ADJ
gra-919	43	42	global	global	ADJ
gra-919	43	43	journal	journal	PROPN
gra-919	43	44	for	for	ADP
gra-919	43	45	research	research	NOUN
gra-919	43	46	analysis	analysis	NOUN
gra-919	43	47	amikacin	amikacin	PROPN
gra-919	43	48	and	and	CCONJ
gra-919	43	49	cloxacillin	cloxacillin	NOUN
gra-919	43	50	for	for	ADP
gra-919	43	51	suspected	suspect	VERB
gra-919	43	52	ate	ate	NOUN
gra-919	43	53	-	-	PUNCT
gra-919	43	54	onset	onset	NOUN
gra-919	43	55	sepsis	sepsis	NOUN
gra-919	43	56	.	.	PUNCT
gra-919	44	1	the	the	DET
gra-919	44	2	l	l	PROPN
gra-919	44	3	comparison	comparison	NOUN
gra-919	44	4	cohorts	cohort	NOUN
gra-919	44	5	were	be	AUX
gra-919	44	6	neonates	neonate	NOUN
gra-919	44	7	receiving	receive	VERB
gra-919	44	8	empiric	empiric	ADJ
gra-919	44	9	cefotaxime	cefotaxime	NOUN
gra-919	44	10	and	and	CCONJ
gra-919	44	11	ampicillin	ampicillin	NOUN
gra-919	44	12	for	for	ADP
gra-919	44	13	suspected	suspect	VERB
gra-919	44	14	late	late	ADJ
gra-919	44	15	-	-	PUNCT
gra-919	44	16	onset	onset	NOUN
gra-919	44	17	sepsis	sepsis	NOUN
gra-919	44	18	.	.	PUNCT
gra-919	45	1	a	a	DET
gra-919	45	2	1:1	1:1	NUM
gra-919	45	3	propensity	propensity	NOUN
gra-919	45	4	score	score	NOUN
gra-919	45	5	matching	matching	NOUN
gra-919	45	6	of	of	ADP
gra-919	45	7	the	the	DET
gra-919	45	8	2	2	NUM
gra-919	45	9	treatment	treatment	NOUN
gra-919	45	10	groups	group	NOUN
gra-919	45	11	to	to	ADP
gra-919	45	12	the	the	DET
gra-919	45	13	nearest	near	ADJ
gra-919	45	14	neighbour	neighbour	NOUN
gra-919	45	15	using	use	VERB
gra-919	45	16	the	the	DET
gra-919	45	17	birth	birth	NOUN
gra-919	45	18	weights	weight	NOUN
gra-919	45	19	,	,	PUNCT
gra-919	45	20	gestational	gestational	ADJ
gra-919	45	21	ages	age	NOUN
gra-919	45	22	,	,	PUNCT
gra-919	45	23	need	need	VERB
gra-919	45	24	for	for	ADP
gra-919	45	25	respiratory	respiratory	ADJ
gra-919	45	26	support	support	NOUN
gra-919	45	27	(	(	PUNCT
gra-919	45	28	received	receive	VERB
gra-919	45	29	ventilatory	ventilatory	ADJ
gra-919	45	30	support	support	NOUN
gra-919	45	31	during	during	ADP
gra-919	45	32	hospitalization	hospitalization	NOUN
gra-919	45	33	)	)	PUNCT
gra-919	45	34	,	,	PUNCT
gra-919	45	35	was	be	AUX
gra-919	45	36	carried	carry	VERB
gra-919	45	37	out	out	ADP
gra-919	45	38	.	.	PUNCT
gra-919	46	1	the	the	DET
gra-919	46	2	primary	primary	ADJ
gra-919	46	3	outcome	outcome	NOUN
gra-919	46	4	of	of	ADP
gra-919	46	5	this	this	DET
gra-919	46	6	study	study	NOUN
gra-919	46	7	was	be	AUX
gra-919	46	8	the	the	DET
gra-919	46	9	all	all	DET
gra-919	46	10	-	-	PUNCT
gra-919	46	11	cause	cause	NOUN
gra-919	46	12	mortality	mortality	NOUN
gra-919	46	13	during	during	ADP
gra-919	46	14	the	the	DET
gra-919	46	15	rst	rst	PROPN
gra-919	46	16	120	120	NUM
gra-919	46	17	days	day	NOUN
gra-919	46	18	of	of	ADP
gra-919	46	19	life	life	NOUN
gra-919	46	20	or	or	CCONJ
gra-919	46	21	discharge	discharge	VERB
gra-919	46	22	.	.	PUNCT
gra-919	47	1	defnitions	defnition	NOUN
gra-919	47	2	clinical	clinical	ADJ
gra-919	47	3	(	(	PUNCT
gra-919	47	4	suspected	suspected	ADJ
gra-919	47	5	)	)	PUNCT
gra-919	47	6	sepsis	sepsis	NOUN
gra-919	47	7	:	:	PUNCT
gra-919	47	8	the	the	DET
gra-919	47	9	exact	exact	ADJ
gra-919	47	10	denition	denition	NOUN
gra-919	47	11	of	of	ADP
gra-919	47	12	suspected	suspect	VERB
gra-919	47	13	neonatal	neonatal	ADJ
gra-919	47	14	sepsis	sepsis	NOUN
gra-919	47	15	remains	remain	VERB
gra-919	47	16	vague	vague	ADJ
gra-919	47	17	.	.	PUNCT
gra-919	48	1	as	as	SCONJ
gra-919	48	2	the	the	DET
gra-919	48	3	clinical	clinical	ADJ
gra-919	48	4	features	feature	NOUN
gra-919	48	5	of	of	ADP
gra-919	48	6	sepsis	sepsis	NOUN
gra-919	48	7	may	may	AUX
gra-919	48	8	be	be	AUX
gra-919	48	9	infuenced	infuence	VERB
gra-919	48	10	by	by	ADP
gra-919	48	11	strong	strong	ADJ
gra-919	48	12	pro	pro	ADJ
gra-919	48	13	-	-	ADJ
gra-919	48	14	infam	infam	NOUN
gra-919	48	15	-	-	PUNCT
gra-919	48	16	matory	matory	NOUN
gra-919	48	17	cytokines	cytokine	NOUN
gra-919	48	18	,	,	PUNCT
gra-919	48	19	clinicians	clinician	NOUN
gra-919	48	20	rely	rely	VERB
gra-919	48	21	on	on	ADP
gra-919	48	22	clinical	clinical	ADJ
gra-919	48	23	features	feature	NOUN
gra-919	48	24	in	in	ADP
gra-919	48	25	their	their	PRON
gra-919	48	26	decision	decision	NOUN
gra-919	48	27	to	to	PART
gra-919	48	28	suspect	suspect	VERB
gra-919	48	29	sepsis	sepsis	NOUN
gra-919	48	30	and	and	CCONJ
gra-919	48	31	start	start	VERB
gra-919	48	32	antimicrobial	antimicrobial	ADJ
gra-919	48	33	agents(11,12,13	agents(11,12,13	NOUN
gra-919	48	34	)	)	PUNCT
gra-919	48	35	.	.	PUNCT
gra-919	49	1	conrmed	conrme	VERB
gra-919	49	2	(	(	PUNCT
gra-919	49	3	proven	prove	VERB
gra-919	49	4	)	)	PUNCT
gra-919	49	5	sepsis	sepsis	NOUN
gra-919	49	6	:	:	PUNCT
gra-919	49	7	detection	detection	NOUN
gra-919	49	8	of	of	ADP
gra-919	49	9	a	a	DET
gra-919	49	10	pathogen	pathogen	NOUN
gra-919	49	11	(	(	PUNCT
gra-919	49	12	positive	positive	ADJ
gra-919	49	13	culture	culture	NOUN
gra-919	49	14	)	)	PUNCT
gra-919	49	15	in	in	ADP
gra-919	49	16	otherwise	otherwise	ADV
gra-919	49	17	sterile	sterile	ADJ
gra-919	49	18	body	body	NOUN
gra-919	49	19	uid	uid	NOUN
gra-919	49	20	,	,	PUNCT
gra-919	49	21	in	in	ADP
gra-919	49	22	addition	addition	NOUN
gra-919	49	23	to	to	ADP
gra-919	49	24	clinical	clinical	ADJ
gra-919	49	25	and	and	CCONJ
gra-919	49	26	laboratory	laboratory	NOUN
gra-919	49	27	signs	sign	NOUN
gra-919	49	28	of	of	ADP
gra-919	49	29	sepsis(11,12,13	sepsis(11,12,13	NOUN
gra-919	49	30	)	)	PUNCT
gra-919	49	31	early	early	ADJ
gra-919	49	32	-	-	PUNCT
gra-919	49	33	onset	onset	NOUN
gra-919	49	34	sepsis	sepsis	NOUN
gra-919	49	35	:	:	PUNCT
gra-919	49	36	sepsis	sepsis	NOUN
gra-919	49	37	caused	cause	VERB
gra-919	49	38	by	by	ADP
gra-919	49	39	pathogens	pathogen	NOUN
gra-919	49	40	transmitted	transmit	VERB
gra-919	49	41	vertically	vertically	ADV
gra-919	49	42	from	from	ADP
gra-919	49	43	mother	mother	NOUN
gra-919	49	44	to	to	ADP
gra-919	49	45	infant	infant	NOUN
gra-919	49	46	occurring	occur	VERB
gra-919	49	47	in	in	ADP
gra-919	49	48	the	the	DET
gra-919	49	49	rst	rst	PROPN
gra-919	49	50	3	3	NUM
gra-919	49	51	days	day	NOUN
gra-919	49	52	of	of	ADP
gra-919	49	53	life(11,12,13	life(11,12,13	NOUN
gra-919	49	54	)	)	PUNCT
gra-919	49	55	.	.	PUNCT
gra-919	50	1	late	late	ADJ
gra-919	50	2	-	-	PUNCT
gra-919	50	3	onset	onset	NOUN
gra-919	50	4	sepsis	sepsis	NOUN
gra-919	50	5	:	:	PUNCT
gra-919	50	6	sepsis	sepsis	NOUN
gra-919	50	7	caused	cause	VERB
gra-919	50	8	by	by	ADP
gra-919	50	9	horizontally	horizontally	ADV
gra-919	50	10	acquired	acquire	VERB
gra-919	50	11	pathogens	pathogen	NOUN
gra-919	50	12	that	that	PRON
gra-919	50	13	occurs	occur	VERB
gra-919	50	14	after	after	ADP
gra-919	50	15	3	3	NUM
gra-919	50	16	days	day	NOUN
gra-919	50	17	of	of	ADP
gra-919	50	18	an	an	DET
gra-919	50	19	infant	infant	NOUN
gra-919	50	20	's	's	PART
gra-919	50	21	life.(11,12,13	life.(11,12,13	NOUN
gra-919	50	22	)	)	PUNCT
gra-919	50	23	blood	blood	NOUN
gra-919	50	24	sample	sample	NOUN
gra-919	50	25	for	for	ADP
gra-919	50	26	culture	culture	NOUN
gra-919	50	27	:	:	PUNCT
gra-919	50	28	we	we	PRON
gra-919	50	29	use	use	VERB
gra-919	50	30	standardized	standardized	ADJ
gra-919	50	31	culture	culture	NOUN
gra-919	50	32	techniques	technique	NOUN
gra-919	50	33	to	to	PART
gra-919	50	34	reduce	reduce	VERB
gra-919	50	35	false	false	ADJ
gra-919	50	36	-	-	PUNCT
gra-919	50	37	negative	negative	ADJ
gra-919	50	38	results	result	NOUN
gra-919	50	39	by	by	ADP
gra-919	50	40	taking	take	VERB
gra-919	50	41	1	1	NUM
gra-919	50	42	-	-	PUNCT
gra-919	50	43	ml	ml	NOUN
gra-919	50	44	blood	blood	NOUN
gra-919	50	45	sample	sample	NOUN
gra-919	50	46	via	via	ADP
gra-919	50	47	venipuncture	venipuncture	NOUN
gra-919	50	48	before	before	ADP
gra-919	50	49	starting	start	VERB
gra-919	50	50	antibiotics	antibiotic	NOUN
gra-919	50	51	.	.	PUNCT
gra-919	51	1	statistical	statistical	ADJ
gra-919	51	2	analysis	analysis	NOUN
gra-919	51	3	the	the	DET
gra-919	51	4	baseline	baseline	ADJ
gra-919	51	5	characteristics	characteristic	NOUN
gra-919	51	6	of	of	ADP
gra-919	51	7	both	both	DET
gra-919	51	8	treatment	treatment	NOUN
gra-919	51	9	groups	group	NOUN
gra-919	51	10	were	be	AUX
gra-919	51	11	compared	compare	VERB
gra-919	51	12	using	use	VERB
gra-919	51	13	chi	chi	ADJ
gra-919	51	14	-	-	PUNCT
gra-919	51	15	square	square	ADJ
gra-919	51	16	and	and	CCONJ
gra-919	51	17	independent	independent	ADJ
gra-919	51	18	t	t	NOUN
gra-919	51	19	tests	test	NOUN
gra-919	51	20	where	where	SCONJ
gra-919	51	21	appropriate	appropriate	ADJ
gra-919	51	22	.	.	PUNCT
gra-919	52	1	results	result	NOUN
gra-919	52	2	:	:	PUNCT
gra-919	52	3	table	table	NOUN
gra-919	52	4	1	1	NUM
gra-919	52	5	table	table	NOUN
gra-919	52	6	2	2	NUM
gra-919	52	7	microrganisms	microrganism	NOUN
gra-919	52	8	recovered	recover	VERB
gra-919	52	9	from	from	ADP
gra-919	52	10	culture	culture	NOUN
gra-919	52	11	we	we	PRON
gra-919	52	12	identied	identied	PROPN
gra-919	52	13	a	a	DET
gra-919	52	14	total	total	NOUN
gra-919	52	15	of	of	ADP
gra-919	52	16	150	150	NUM
gra-919	52	17	vlbw	vlbw	NOUN
gra-919	52	18	neonates	neonate	NOUN
gra-919	52	19	who	who	PRON
gra-919	52	20	had	have	AUX
gra-919	52	21	received	receive	VERB
gra-919	52	22	empiric	empiric	ADJ
gra-919	52	23	amikacin	amikacin	PROPN
gra-919	52	24	–	–	PUNCT
gra-919	52	25	cloxacillin	cloxacillin	NOUN
gra-919	52	26	or	or	CCONJ
gra-919	52	27	cefotaxime	cefotaxime	NOUN
gra-919	52	28	–	–	PUNCT
gra-919	52	29	ampicillin	ampicillin	NOUN
gra-919	52	30	for	for	ADP
gra-919	52	31	late	late	ADJ
gra-919	52	32	-	-	PUNCT
gra-919	52	33	onset	onset	NOUN
gra-919	52	34	sepsis	sepsis	NOUN
gra-919	52	35	.	.	PUNCT
gra-919	53	1	thirty	thirty	NUM
gra-919	53	2	-	-	PUNCT
gra-919	53	3	six	six	NUM
gra-919	53	4	cases	case	NOUN
gra-919	53	5	had	have	VERB
gra-919	53	6	reports	report	NOUN
gra-919	53	7	of	of	ADP
gra-919	53	8	isolated	isolated	ADJ
gra-919	53	9	microorganisms	microorganism	NOUN
gra-919	53	10	.	.	PUNCT
gra-919	54	1	the	the	DET
gra-919	54	2	commonly	commonly	ADV
gra-919	54	3	isolated	isolate	VERB
gra-919	54	4	organisms	organism	NOUN
gra-919	54	5	include	include	VERB
gra-919	54	6	staphylococcus	staphylococcus	NOUN
gra-919	54	7	epidermidis	epidermidi	NOUN
gra-919	54	8	(	(	PUNCT
gra-919	54	9	21	21	NUM
gra-919	54	10	cases	case	NOUN
gra-919	54	11	)	)	PUNCT
gra-919	54	12	,	,	PUNCT
gra-919	54	13	acinetobacter	acinetobacter	ADV
gra-919	54	14	baumannii	baumannii	ADJ
gra-919	54	15	(	(	PUNCT
gra-919	54	16	3	3	NUM
gra-919	54	17	cases	case	NOUN
gra-919	54	18	)	)	PUNCT
gra-919	54	19	,	,	PUNCT
gra-919	54	20	and	and	CCONJ
gra-919	54	21	enterobacter	enterobacter	ADJ
gra-919	54	22	cloacae	cloacae	NOUN
gra-919	54	23	(	(	PUNCT
gra-919	54	24	3	3	NUM
gra-919	54	25	cases	case	NOUN
gra-919	54	26	)	)	PUNCT
gra-919	54	27	(	(	PUNCT
gra-919	54	28	table	table	NOUN
gra-919	54	29	2	2	NUM
gra-919	54	30	)	)	PUNCT
gra-919	54	31	,	,	PUNCT
gra-919	54	32	e.	e.	PROPN
gra-919	54	33	coli	coli	PROPN
gra-919	54	34	(	(	PUNCT
gra-919	54	35	2	2	NUM
gra-919	54	36	cases	case	NOUN
gra-919	54	37	)	)	PUNCT
gra-919	54	38	,	,	PUNCT
gra-919	54	39	candida	candida	PROPN
gra-919	54	40	sp	sp	PROPN
gra-919	54	41	.	.	PUNCT
gra-919	55	1	(	(	PUNCT
gra-919	55	2	1	1	NUM
gra-919	55	3	case	case	NOUN
gra-919	55	4	)	)	PUNCT
gra-919	55	5	.	.	PUNCT
gra-919	56	1	one	one	NUM
gra-919	56	2	hundred	hundred	NUM
gra-919	56	3	and	and	CCONJ
gra-919	56	4	eighteen	eighteen	NUM
gra-919	56	5	neonates	neonate	NOUN
gra-919	56	6	received	receive	VERB
gra-919	56	7	amikacin	amikacin	PROPN
gra-919	56	8	–	–	PUNCT
gra-919	56	9	cloxacillin	cloxacillin	NOUN
gra-919	56	10	,	,	PUNCT
gra-919	56	11	whereas	whereas	SCONJ
gra-919	56	12	32	32	NUM
gra-919	56	13	received	receive	VERB
gra-919	56	14	cefotaxime	cefotaxime	NOUN
gra-919	56	15	–	–	PUNCT
gra-919	56	16	ampicillin	ampicillin	NOUN
gra-919	56	17	.	.	PUNCT
gra-919	57	1	the	the	DET
gra-919	57	2	median	median	ADJ
gra-919	57	3	duration	duration	NOUN
gra-919	57	4	of	of	ADP
gra-919	57	5	hospitalization	hospitalization	NOUN
gra-919	57	6	among	among	ADP
gra-919	57	7	the	the	DET
gra-919	57	8	patients	patient	NOUN
gra-919	57	9	was	be	AUX
gra-919	57	10	42	42	NUM
gra-919	57	11	(	(	PUNCT
gra-919	57	12	31–71	31–71	NUM
gra-919	57	13	)	)	PUNCT
gra-919	57	14	days	day	NOUN
gra-919	57	15	,	,	PUNCT
gra-919	57	16	and	and	CCONJ
gra-919	57	17	the	the	DET
gra-919	57	18	duration	duration	NOUN
gra-919	57	19	of	of	ADP
gra-919	57	20	antibiotics	antibiotic	NOUN
gra-919	57	21	during	during	ADP
gra-919	57	22	hospitalization	hospitalization	NOUN
gra-919	57	23	was	be	AUX
gra-919	57	24	23	23	NUM
gra-919	57	25	(	(	PUNCT
gra-919	57	26	iqr	iqr	NOUN
gra-919	57	27	:	:	PUNCT
gra-919	57	28	9–26	9–26	ADJ
gra-919	57	29	)	)	PUNCT
gra-919	57	30	days	day	NOUN
gra-919	57	31	.	.	PUNCT
gra-919	58	1	the	the	DET
gra-919	58	2	neonates	neonate	NOUN
gra-919	58	3	received	receive	VERB
gra-919	58	4	an	an	DET
gra-919	58	5	average	average	NOUN
gra-919	58	6	of	of	ADP
gra-919	58	7	3	3	NUM
gra-919	58	8	courses	course	NOUN
gra-919	58	9	of	of	ADP
gra-919	58	10	antibiotics	antibiotic	NOUN
gra-919	58	11	during	during	ADP
gra-919	58	12	hospitalization	hospitalization	NOUN
gra-919	58	13	.	.	PUNCT
gra-919	59	1	after	after	ADP
gra-919	59	2	1:1	1:1	NUM
gra-919	59	3	matching	matching	NOUN
gra-919	59	4	of	of	ADP
gra-919	59	5	neonates	neonate	NOUN
gra-919	59	6	in	in	ADP
gra-919	59	7	both	both	DET
gra-919	59	8	treatment	treatment	NOUN
gra-919	59	9	groups	group	NOUN
gra-919	59	10	,	,	PUNCT
gra-919	59	11	we	we	PRON
gra-919	59	12	included	include	VERB
gra-919	59	13	32	32	NUM
gra-919	59	14	neonates	neonate	NOUN
gra-919	59	15	each	each	PRON
gra-919	59	16	in	in	ADP
gra-919	59	17	the	the	DET
gra-919	59	18	amikacin	amikacin	PROPN
gra-919	59	19	–	–	PUNCT
gra-919	59	20	cloxacillin	cloxacillin	NOUN
gra-919	59	21	and	and	CCONJ
gra-919	59	22	cefotaxime	cefotaxime	NOUN
gra-919	59	23	–	–	PUNCT
gra-919	59	24	ampicillin	ampicillin	NOUN
gra-919	59	25	groups	group	NOUN
gra-919	59	26	.	.	PUNCT
gra-919	60	1	of	of	ADP
gra-919	60	2	those	those	PRON
gra-919	60	3	included	include	VERB
gra-919	60	4	in	in	ADP
gra-919	60	5	the	the	DET
gra-919	60	6	study	study	NOUN
gra-919	60	7	,	,	PUNCT
gra-919	60	8	54.7	54.7	NUM
gra-919	60	9	%	%	NOUN
gra-919	60	10	(	(	PUNCT
gra-919	60	11	35/64	35/64	NOUN
gra-919	60	12	)	)	PUNCT
gra-919	60	13	were	be	AUX
gra-919	60	14	females	female	NOUN
gra-919	60	15	.	.	PUNCT
gra-919	61	1	the	the	DET
gra-919	61	2	mean	mean	ADJ
gra-919	61	3	gestational	gestational	ADJ
gra-919	61	4	age	age	NOUN
gra-919	61	5	of	of	ADP
gra-919	61	6	all	all	DET
gra-919	61	7	the	the	DET
gra-919	61	8	neonates	neonate	NOUN
gra-919	61	9	in	in	ADP
gra-919	61	10	the	the	DET
gra-919	61	11	study	study	NOUN
gra-919	61	12	was	be	AUX
gra-919	61	13	27.4	27.4	NUM
gra-919	61	14	weeks	week	NOUN
gra-919	61	15	,	,	PUNCT
gra-919	61	16	and	and	CCONJ
gra-919	61	17	the	the	DET
gra-919	61	18	mean	mean	ADJ
gra-919	61	19	birth	birth	NOUN
gra-919	61	20	weight	weight	NOUN
gra-919	61	21	was	be	AUX
gra-919	61	22	918	918	NUM
gra-919	61	23	g.	g.	NOUN
gra-919	61	24	the	the	DET
gra-919	61	25	risk	risk	NOUN
gra-919	61	26	of	of	ADP
gra-919	61	27	mortality	mortality	NOUN
gra-919	61	28	was	be	AUX
gra-919	61	29	signifcantly	signifcantly	ADV
gra-919	61	30	higher	high	ADJ
gra-919	61	31	among	among	ADP
gra-919	61	32	neonates	neonate	NOUN
gra-919	61	33	who	who	PRON
gra-919	61	34	received	receive	VERB
gra-919	61	35	empiric	empiric	ADJ
gra-919	61	36	cefotaxime	cefotaxime	NOUN
gra-919	61	37	and	and	CCONJ
gra-919	61	38	ampicillin	ampicillin	NOUN
gra-919	61	39	compared	compare	VERB
gra-919	61	40	with	with	ADP
gra-919	61	41	those	those	PRON
gra-919	61	42	who	who	PRON
gra-919	61	43	received	receive	VERB
gra-919	61	44	amikacin	amikacin	PROPN
gra-919	61	45	and	and	CCONJ
gra-919	61	46	cloxacillin	cloxacillin	NOUN
gra-919	61	47	(	(	PUNCT
gra-919	61	48	hazard	hazard	NOUN
gra-919	61	49	ratio	ratio	NOUN
gra-919	61	50	:	:	PUNCT
gra-919	61	51	2.91	2.91	NUM
gra-919	61	52	,	,	PUNCT
gra-919	61	53	95	95	NUM
gra-919	61	54	%	%	NOUN
gra-919	61	55	condence	condence	NOUN
gra-919	61	56	interval	interval	NOUN
gra-919	61	57	:	:	PUNCT
gra-919	61	58	1.17–7.30	1.17–7.30	NUM
gra-919	61	59	,	,	PUNCT
gra-919	61	60	p	p	NOUN
gra-919	61	61	=	=	NOUN
gra-919	61	62	0.023	0.023	NUM
gra-919	61	63	)	)	PUNCT
gra-919	61	64	discussion	discussion	NOUN
gra-919	61	65	in	in	ADP
gra-919	61	66	this	this	DET
gra-919	61	67	study	study	NOUN
gra-919	61	68	,	,	PUNCT
gra-919	61	69	we	we	PRON
gra-919	61	70	found	find	VERB
gra-919	61	71	a	a	DET
gra-919	61	72	lower	low	ADJ
gra-919	61	73	risk	risk	NOUN
gra-919	61	74	of	of	ADP
gra-919	61	75	mortality	mortality	NOUN
gra-919	61	76	among	among	ADP
gra-919	61	77	neonates	neonate	NOUN
gra-919	61	78	receiving	receive	VERB
gra-919	61	79	empiric	empiric	ADJ
gra-919	61	80	amikacin	amikacin	PROPN
gra-919	61	81	–	–	PUNCT
gra-919	61	82	cloxacillin	cloxacillin	NOUN
gra-919	61	83	for	for	ADP
gra-919	61	84	lateonset	lateonset	NOUN
gra-919	61	85	neonatal	neonatal	ADJ
gra-919	61	86	sepsis	sepsis	NOUN
gra-919	61	87	,	,	PUNCT
gra-919	61	88	compared	compare	VERB
gra-919	61	89	with	with	ADP
gra-919	61	90	cefotaxime	cefotaxime	NOUN
gra-919	61	91	–	–	PUNCT
gra-919	61	92	ampicillin	ampicillin	NOUN
gra-919	61	93	treatment	treatment	NOUN
gra-919	61	94	.	.	PUNCT
gra-919	62	1	cloxacillin	cloxacillin	NOUN
gra-919	62	2	,	,	PUNCT
gra-919	62	3	cefotaxime	cefotaxime	NOUN
gra-919	62	4	,	,	PUNCT
gra-919	62	5	and	and	CCONJ
gra-919	62	6	ampicillin	ampicillin	NOUN
gra-919	62	7	are	be	AUX
gra-919	62	8	generally	generally	ADV
gra-919	62	9	protective	protective	ADJ
gra-919	62	10	for	for	ADP
gra-919	62	11	gram	gram	NOUN
gra-919	62	12	-	-	PUNCT
gra-919	62	13	positive	positive	ADJ
gra-919	62	14	bacteria	bacteria	NOUN
gra-919	62	15	and	and	CCONJ
gra-919	62	16	amikacin	amikacin	PROPN
gra-919	62	17	and	and	CCONJ
gra-919	62	18	cefotaxime	cefotaxime	NOUN
gra-919	62	19	for	for	ADP
gra-919	62	20	gram	gram	NOUN
gra-919	62	21	-	-	PUNCT
gra-919	62	22	negative	negative	ADJ
gra-919	62	23	organisms	organism	NOUN
gra-919	62	24	.	.	PUNCT
gra-919	63	1	however	however	ADV
gra-919	63	2	,	,	PUNCT
gra-919	63	3	cefotaxime	cefotaxime	NOUN
gra-919	63	4	may	may	AUX
gra-919	63	5	not	not	PART
gra-919	63	6	always	always	ADV
gra-919	63	7	provide	provide	VERB
gra-919	63	8	sufcient	sufcient	ADJ
gra-919	63	9	gram	gram	NOUN
gra-919	63	10	-	-	PUNCT
gra-919	63	11	negative	negative	ADJ
gra-919	63	12	antibacterial	antibacterial	ADJ
gra-919	63	13	coverage	coverage	NOUN
gra-919	63	14	,	,	PUNCT
gra-919	63	15	with	with	ADP
gra-919	63	16	only	only	ADV
gra-919	63	17	about	about	ADV
gra-919	63	18	75	75	NUM
gra-919	63	19	%	%	NOUN
gra-919	63	20	of	of	ADP
gra-919	63	21	the	the	DET
gra-919	63	22	enterobacteriaceae	enterobacteriaceae	NOUN
gra-919	63	23	other	other	ADJ
gra-919	63	24	than	than	ADP
gra-919	63	25	e.	e.	PROPN
gra-919	63	26	coli	coli	PROPN
gra-919	63	27	and	and	CCONJ
gra-919	63	28	46	46	NUM
gra-919	63	29	%	%	NOUN
gra-919	63	30	of	of	ADP
gra-919	63	31	the	the	DET
gra-919	63	32	pseudomonas	pseudomona	NOUN
gra-919	63	33	spp	spp	NOUN
gra-919	63	34	.	.	PUNCT
gra-919	63	35	susceptible	susceptible	ADJ
gra-919	63	36	in	in	ADP
gra-919	63	37	the	the	DET
gra-919	63	38	united	united	PROPN
gra-919	63	39	kingdom.14	kingdom.14	PROPN
gra-919	63	40	several	several	ADJ
gra-919	63	41	studies	study	NOUN
gra-919	63	42	have	have	AUX
gra-919	63	43	reported	report	VERB
gra-919	63	44	an	an	DET
gra-919	63	45	increased	increase	VERB
gra-919	63	46	risk	risk	NOUN
gra-919	63	47	of	of	ADP
gra-919	63	48	fungal	fungal	ADJ
gra-919	63	49	infection	infection	NOUN
gra-919	63	50	,	,	PUNCT
gra-919	63	51	death	death	NOUN
gra-919	63	52	,	,	PUNCT
gra-919	63	53	and	and	CCONJ
gra-919	63	54	neurodevelopmental	neurodevelopmental	ADJ
gra-919	63	55	delay	delay	NOUN
gra-919	63	56	with	with	ADP
gra-919	63	57	starting	start	VERB
gra-919	63	58	cefotaxime	cefotaxime	NOUN
gra-919	63	59	in	in	ADP
gra-919	63	60	the	the	DET
gra-919	63	61	rst	rst	PROPN
gra-919	63	62	few	few	ADJ
gra-919	63	63	days	day	NOUN
gra-919	63	64	of	of	ADP
gra-919	63	65	life.15,16	life.15,16	ADJ
gra-919	63	66	clark	clark	PROPN
gra-919	63	67	et	et	PROPN
gra-919	63	68	al	al	PROPN
gra-919	63	69	reported	report	VERB
gra-919	63	70	a	a	DET
gra-919	63	71	higher	high	ADJ
gra-919	63	72	mortality	mortality	NOUN
gra-919	63	73	rate	rate	NOUN
gra-919	63	74	among	among	ADP
gra-919	63	75	infants	infant	NOUN
gra-919	63	76	who	who	PRON
gra-919	63	77	had	have	AUX
gra-919	63	78	received	receive	VERB
gra-919	63	79	cefotaxime	cefotaxime	NOUN
gra-919	63	80	in	in	ADP
gra-919	63	81	the	the	DET
gra-919	63	82	rst	rst	PROPN
gra-919	63	83	week	week	NOUN
gra-919	63	84	of	of	ADP
gra-919	63	85	life	life	NOUN
gra-919	63	86	,	,	PUNCT
gra-919	63	87	compared	compare	VERB
gra-919	63	88	with	with	ADP
gra-919	63	89	gentamicin.16	gentamicin.16	PROPN
gra-919	63	90	resistance	resistance	NOUN
gra-919	63	91	to	to	ADP
gra-919	63	92	cefotaxime	cefotaxime	NOUN
gra-919	63	93	is	be	AUX
gra-919	63	94	increasing	increase	VERB
gra-919	63	95	on	on	ADP
gra-919	63	96	account	account	NOUN
gra-919	63	97	of	of	ADP
gra-919	63	98	extended	extend	VERB
gra-919	63	99	-	-	PUNCT
gra-919	63	100	spectrum	spectrum	NOUN
gra-919	63	101	beta	beta	NOUN
gra-919	63	102	-	-	PUNCT
gra-919	63	103	lactamase	lactamase	NOUN
gra-919	63	104	infections	infection	NOUN
gra-919	63	105	,	,	PUNCT
gra-919	63	106	commonly	commonly	ADV
gra-919	63	107	by	by	ADP
gra-919	63	108	a.	a.	PROPN
gra-919	63	109	baumannii	baumannii	PROPN
gra-919	63	110	,	,	PUNCT
gra-919	63	111	k.	k.	NOUN
gra-919	63	112	pneumonia	pneumonia	NOUN
gra-919	63	113	,	,	PUNCT
gra-919	63	114	and	and	CCONJ
gra-919	63	115	e.	e.	PROPN
gra-919	63	116	coli.17	coli.17	PROPN
gra-919	63	117	coagulase	coagulase	PROPN
gra-919	63	118	-	-	PUNCT
gra-919	63	119	negative	negative	ADJ
gra-919	63	120	staphylococci	staphylococci	NOUN
gra-919	63	121	(	(	PUNCT
gra-919	63	122	cons	con	NOUN
gra-919	63	123	)	)	PUNCT
gra-919	63	124	are	be	AUX
gra-919	63	125	the	the	DET
gra-919	63	126	most	most	ADV
gra-919	63	127	frequent	frequent	ADJ
gra-919	63	128	bacteria	bacteria	NOUN
gra-919	63	129	isolates	isolate	NOUN
gra-919	63	130	in	in	ADP
gra-919	63	131	late	late	ADJ
gra-919	63	132	-	-	PUNCT
gra-919	63	133	onset	onset	NOUN
gra-919	63	134	neonatal	neonatal	ADJ
gra-919	63	135	sepsis	sepsis	NOUN
gra-919	63	136	..	..	PUNCT
gra-919	63	137	although	although	SCONJ
gra-919	63	138	cons	con	NOUN
gra-919	63	139	are	be	AUX
gra-919	63	140	often	often	ADV
gra-919	63	141	susceptible	susceptible	ADJ
gra-919	63	142	to	to	ADP
gra-919	63	143	vancomycin	vancomycin	PROPN
gra-919	63	144	,	,	PUNCT
gra-919	63	145	targeted	target	VERB
gra-919	63	146	empiric	empiric	ADJ
gra-919	63	147	therapy	therapy	NOUN
gra-919	63	148	with	with	ADP
gra-919	63	149	vancomycin	vancomycin	PROPN
gra-919	63	150	is	be	AUX
gra-919	63	151	usually	usually	ADV
gra-919	63	152	reserved	reserve	VERB
gra-919	63	153	for	for	ADP
gra-919	63	154	neonates	neonate	NOUN
gra-919	63	155	with	with	ADP
gra-919	63	156	the	the	DET
gra-919	63	157	highest	high	ADJ
gra-919	63	158	risk	risk	NOUN
gra-919	63	159	of	of	ADP
gra-919	63	160	severe	severe	ADJ
gra-919	63	161	infections.11	infections.11	NOUN
gra-919	63	162	an	an	DET
gra-919	63	163	ideal	ideal	ADJ
gra-919	63	164	antibiotic	antibiotic	ADJ
gra-919	63	165	combination	combination	NOUN
gra-919	63	166	regimen	regimen	NOUN
gra-919	63	167	should	should	AUX
gra-919	63	168	cover	cover	VERB
gra-919	63	169	the	the	DET
gra-919	63	170	most	most	ADV
gra-919	63	171	frequently	frequently	ADV
gra-919	63	172	isolated	isolate	VERB
gra-919	63	173	organisms	organism	NOUN
gra-919	63	174	,	,	PUNCT
gra-919	63	175	without	without	ADP
gra-919	63	176	causing	cause	VERB
gra-919	63	177	selection	selection	NOUN
gra-919	63	178	pressure	pressure	NOUN
gra-919	63	179	for	for	ADP
gra-919	63	180	antibiotic	antibiotic	ADJ
gra-919	63	181	resistance	resistance	NOUN
gra-919	63	182	.	.	PUNCT
gra-919	64	1	the	the	DET
gra-919	64	2	strategies	strategy	NOUN
gra-919	64	3	adopted	adopt	VERB
gra-919	64	4	by	by	ADP
gra-919	64	5	various	various	ADJ
gra-919	64	6	nicus	nicus	NOUN
gra-919	64	7	to	to	PART
gra-919	64	8	prevent	prevent	VERB
gra-919	64	9	and	and	CCONJ
gra-919	64	10	treat	treat	VERB
gra-919	64	11	late	late	ADJ
gra-919	64	12	-	-	PUNCT
gra-919	64	13	onset	onset	NOUN
gra-919	64	14	neonatal	neonatal	ADJ
gra-919	64	15	sepsis	sepsis	NOUN
gra-919	64	16	may	may	AUX
gra-919	64	17	inuence	inuence	PROPN
gra-919	64	18	the	the	DET
gra-919	64	19	pattern	pattern	NOUN
gra-919	64	20	of	of	ADP
gra-919	64	21	bacteria	bacteria	NOUN
gra-919	64	22	,	,	PUNCT
gra-919	64	23	causing	cause	VERB
gra-919	64	24	sepsis	sepsis	NOUN
gra-919	64	25	in	in	ADP
gra-919	64	26	the	the	DET
gra-919	64	27	r	r	NOUN
gra-919	64	28	e	e	NOUN
gra-919	64	29	s	s	X
gra-919	64	30	p	p	X
gra-919	64	31	e	e	PROPN
gra-919	64	32	c	c	PROPN
gra-919	64	33	t	t	PROPN
gra-919	64	34	i	i	PRON
gra-919	64	35	v	v	NUM
gra-919	64	36	e	e	X
gra-919	64	37	u	u	NOUN
gra-919	65	1	n	n	ADV
gra-919	66	1	i	i	PRON
gra-919	66	2	t	t	NOUN
gra-919	66	3	s	s	PRON
gra-919	66	4	.	.	PUNCT
gra-919	67	1	f	f	X
gra-919	68	1	o	o	NOUN
gra-919	68	2	r	r	NOUN
gra-919	68	3	e	e	NOUN
gra-919	68	4	x	x	X
gra-919	68	5	a	a	DET
gra-919	68	6	m	m	NOUN
gra-919	68	7	p	p	NOUN
gra-919	68	8	l	l	NOUN
gra-919	68	9	e	e	NOUN
gra-919	68	10	,	,	PUNCT
gra-919	68	11	t	t	PROPN
gra-919	68	12	h	h	NOUN
gra-919	68	13	e	e	X
gra-919	68	14	u	u	NOUN
gra-919	68	15	s	s	X
gra-919	68	16	e	e	NOUN
gra-919	68	17	o	o	X
gra-919	68	18	f	f	X
gra-919	68	19	cefotaxime	cefotaxime	NOUN
gra-919	68	20	–	–	PUNCT
gra-919	68	21	amoxicillin	amoxicillin	NOUN
gra-919	68	22	in	in	ADP
gra-919	68	23	an	an	DET
gra-919	68	24	nicu	nicu	NOUN
gra-919	68	25	may	may	AUX
gra-919	68	26	increase	increase	VERB
gra-919	68	27	the	the	DET
gra-919	68	28	risk	risk	NOUN
gra-919	68	29	of	of	ADP
gra-919	68	30	cefotaxime	cefotaxime	NOUN
gra-919	68	31	resistance	resistance	NOUN
gra-919	68	32	to	to	ADP
gra-919	68	33	gram	gram	NOUN
gra-919	68	34	-	-	PUNCT
gra-919	68	35	negative	negative	ADJ
gra-919	68	36	organisms	organism	NOUN
gra-919	68	37	.	.	PUNCT
gra-919	69	1	thus	thus	ADV
gra-919	69	2	,	,	PUNCT
gra-919	69	3	with	with	ADP
gra-919	69	4	ampicillin	ampicillin	NOUN
gra-919	69	5	–	–	PUNCT
gra-919	69	6	cefotaxime	cefotaxime	NOUN
gra-919	69	7	,	,	PUNCT
gra-919	69	8	gram	gram	NOUN
gra-919	69	9	-	-	PUNCT
gra-919	69	10	negative	negative	ADJ
gra-919	69	11	bacteria	bacteria	NOUN
gra-919	69	12	like	like	ADP
gra-919	69	13	enterobacter	enterobacter	NOUN
gra-919	69	14	spp	spp	NOUN
gra-919	69	15	.	.	PUNCT
gra-919	70	1	may	may	AUX
gra-919	70	2	ourish	ourish	ADP
gra-919	70	3	following	follow	VERB
gra-919	70	4	the	the	DET
gra-919	70	5	elimination	elimination	NOUN
gra-919	70	6	of	of	ADP
gra-919	70	7	normal	normal	ADJ
gra-919	70	8	intestinal	intestinal	ADJ
gra-919	70	9	ora	ora	NOUN
gra-919	70	10	.	.	PUNCT
gra-919	71	1	these	these	DET
gra-919	71	2	organisms	organism	NOUN
gra-919	71	3	may	may	AUX
gra-919	71	4	degrade	degrade	VERB
gra-919	71	5	cefotaxime	cefotaxime	NOUN
gra-919	71	6	and	and	CCONJ
gra-919	71	7	cause	cause	VERB
gra-919	71	8	cefotaxime	cefotaxime	NOUN
gra-919	71	9	-	-	PUNCT
gra-919	71	10	resistant	resistant	ADJ
gra-919	71	11	invasive	invasive	ADJ
gra-919	71	12	infections	infection	NOUN
gra-919	71	13	..	..	PUNCT
gra-919	72	1	it	it	PRON
gra-919	72	2	is	be	AUX
gra-919	72	3	noteworthy	noteworthy	ADJ
gra-919	72	4	that	that	SCONJ
gra-919	72	5	the	the	DET
gra-919	72	6	selection	selection	NOUN
gra-919	72	7	of	of	ADP
gra-919	72	8	antibiotics	antibiotic	NOUN
gra-919	72	9	in	in	ADP
gra-919	72	10	this	this	DET
gra-919	72	11	study	study	NOUN
gra-919	72	12	was	be	AUX
gra-919	72	13	not	not	PART
gra-919	72	14	informed	inform	VERB
gra-919	72	15	by	by	ADP
gra-919	72	16	a	a	DET
gra-919	72	17	change	change	NOUN
gra-919	72	18	in	in	ADP
gra-919	72	19	practice	practice	NOUN
gra-919	72	20	over	over	ADP
gra-919	72	21	time	time	NOUN
gra-919	72	22	;	;	PUNCT
gra-919	72	23	rather	rather	ADV
gra-919	72	24	,	,	PUNCT
gra-919	72	25	it	it	PRON
gra-919	72	26	was	be	AUX
gra-919	72	27	based	base	VERB
gra-919	72	28	on	on	ADP
gra-919	72	29	the	the	DET
gra-919	72	30	hospital	hospital	NOUN
gra-919	72	31	guidelines	guideline	NOUN
gra-919	72	32	premised	premise	VERB
gra-919	72	33	on	on	ADP
gra-919	72	34	the	the	DET
gra-919	72	35	factors	factor	NOUN
gra-919	72	36	mentioned	mention	VERB
gra-919	72	37	earlier	early	ADV
gra-919	72	38	.	.	PUNCT
gra-919	73	1	the	the	DET
gra-919	73	2	rst	rst	PROPN
gra-919	73	3	-	-	PUNCT
gra-919	73	4	line	line	NOUN
gra-919	73	5	empiric	empiric	ADJ
gra-919	73	6	treatment	treatment	NOUN
gra-919	73	7	for	for	ADP
gra-919	73	8	late	late	ADJ
gra-919	73	9	-	-	PUNCT
gra-919	73	10	onset	onset	NOUN
gra-919	73	11	sepsis	sepsis	NOUN
gra-919	73	12	in	in	ADP
gra-919	73	13	our	our	PRON
gra-919	73	14	center	center	NOUN
gra-919	73	15	is	be	AUX
gra-919	73	16	a	a	DET
gra-919	73	17	combination	combination	NOUN
gra-919	73	18	of	of	ADP
gra-919	73	19	amikacin	amikacin	PROPN
gra-919	73	20	and	and	CCONJ
gra-919	73	21	cloxacillin	cloxacillin	NOUN
gra-919	73	22	.	.	PUNCT
gra-919	74	1	consequently	consequently	ADV
gra-919	74	2	,	,	PUNCT
gra-919	74	3	more	more	ADJ
gra-919	74	4	neonates	neonate	NOUN
gra-919	74	5	received	receive	VERB
gra-919	74	6	this	this	DET
gra-919	74	7	regimen	regimen	NOUN
gra-919	74	8	compared	compare	VERB
gra-919	74	9	with	with	ADP
gra-919	74	10	ampicillin	ampicillin	ADJ
gra-919	74	11	–	–	PUNCT
gra-919	74	12	cefotaxime	cefotaxime	NOUN
gra-919	74	13	.	.	PUNCT
gra-919	75	1	this	this	DET
gra-919	75	2	study	study	NOUN
gra-919	75	3	,	,	PUNCT
gra-919	75	4	to	to	ADP
gra-919	75	5	our	our	PRON
gra-919	75	6	knowledge	knowledge	NOUN
gra-919	75	7	,	,	PUNCT
gra-919	75	8	is	be	AUX
gra-919	75	9	among	among	ADP
gra-919	75	10	the	the	DET
gra-919	75	11	rst	rst	PROPN
gra-919	75	12	to	to	PART
gra-919	75	13	compare	compare	VERB
gra-919	75	14	empiric	empiric	ADJ
gra-919	75	15	amikacin	amikacin	PROPN
gra-919	75	16	–	–	PUNCT
gra-919	75	17	cloxacillin	cloxacillin	NOUN
gra-919	75	18	with	with	ADP
gra-919	75	19	cefotaxime	cefotaxime	NOUN
gra-919	75	20	–	–	PUNCT
gra-919	75	21	ampicillin	ampicillin	NOUN
gra-919	75	22	for	for	ADP
gra-919	75	23	lateonset	lateonset	NOUN
gra-919	75	24	neonatal	neonatal	ADJ
gra-919	75	25	sepsis	sepsis	NOUN
gra-919	75	26	..	..	PUNCT
gra-919	75	27	however	however	ADV
gra-919	75	28	,	,	PUNCT
gra-919	75	29	the	the	DET
gra-919	75	30	study	study	NOUN
gra-919	75	31	is	be	AUX
gra-919	75	32	limited	limit	VERB
gra-919	75	33	by	by	ADP
gra-919	75	34	the	the	DET
gra-919	75	35	small	small	ADJ
gra-919	75	36	sample	sample	NOUN
gra-919	75	37	size	size	NOUN
gra-919	75	38	,	,	PUNCT
gra-919	75	39	which	which	PRON
gra-919	75	40	limits	limit	VERB
gra-919	75	41	the	the	DET
gra-919	75	42	generalizability	generalizability	NOUN
gra-919	75	43	of	of	ADP
gra-919	75	44	the	the	DET
gra-919	75	45	volume-8	volume-8	PROPN
gra-919	75	46	,	,	PUNCT
gra-919	75	47	issue-12	issue-12	NOUN
gra-919	75	48	,	,	PUNCT
gra-919	75	49	december-2019	december-2019	ADJ
gra-919	75	50	•	•	NUM
gra-919	75	51	print	print	NOUN
gra-919	75	52	issn	issn	PROPN
gra-919	75	53	no	no	NOUN
gra-919	75	54	.	.	PROPN
gra-919	75	55	2277	2277	NUM
gra-919	76	1	8160	8160	NUM
gra-919	76	2	•	•	NOUN
gra-919	76	3	doi	doi	NOUN
gra-919	76	4	:	:	PUNCT
gra-919	76	5	10.36106	10.36106	NUM
gra-919	76	6	/	/	SYM
gra-919	76	7	gjra	gjra	ADJ
gra-919	76	8	amikacin+	amikacin+	ADJ
gra-919	76	9	cloxacillin	cloxacillin	NOUN
gra-919	76	10	(	(	PUNCT
gra-919	76	11	32	32	NUM
gra-919	76	12	)	)	PUNCT
gra-919	76	13	cefotaxime+	cefotaxime+	NOUN
gra-919	76	14	ampicillin	ampicillin	NOUN
gra-919	76	15	(	(	PUNCT
gra-919	76	16	32	32	NUM
gra-919	76	17	)	)	PUNCT
gra-919	76	18	p	p	NOUN
gra-919	76	19	mean	mean	PROPN
gra-919	76	20	ga	ga	PROPN
gra-919	76	21	,	,	PUNCT
gra-919	76	22	wk	wk	X
gra-919	76	23	(	(	PUNCT
gra-919	76	24	sd	sd	NOUN
gra-919	76	25	)	)	PUNCT
gra-919	76	26	27.4	27.4	NUM
gra-919	76	27	(	(	PUNCT
gra-919	76	28	2.7	2.7	NUM
gra-919	76	29	)	)	PUNCT
gra-919	76	30	27.0	27.0	NUM
gra-919	76	31	(	(	PUNCT
gra-919	76	32	3.3	3.3	NUM
gra-919	76	33	)	)	PUNCT
gra-919	76	34	0.585	0.585	NUM
gra-919	76	35	mean	mean	VERB
gra-919	76	36	birth	birth	NOUN
gra-919	76	37	weight	weight	NOUN
gra-919	76	38	,	,	PUNCT
gra-919	76	39	g	g	PROPN
gra-919	76	40	(	(	PUNCT
gra-919	76	41	sd	sd	NOUN
gra-919	76	42	)	)	PUNCT
gra-919	76	43	937.6	937.6	NUM
gra-919	76	44	(	(	PUNCT
gra-919	76	45	323.8	323.8	NUM
gra-919	76	46	)	)	PUNCT
gra-919	76	47	898.3	898.3	NUM
gra-919	76	48	(	(	PUNCT
gra-919	76	49	388.1	388.1	NUM
gra-919	76	50	)	)	PUNCT
gra-919	76	51	0.639	0.639	NUM
gra-919	76	52	male	male	NOUN
gra-919	76	53	(	(	PUNCT
gra-919	76	54	%	%	NOUN
gra-919	76	55	)	)	PUNCT
gra-919	76	56	17	17	NUM
gra-919	76	57	(	(	PUNCT
gra-919	76	58	53.1	53.1	NUM
gra-919	76	59	)	)	PUNCT
gra-919	76	60	12(37.5	12(37.5	NOUN
gra-919	76	61	)	)	PUNCT
gra-919	76	62	0.054	0.054	NUM
gra-919	76	63	pda	pda	NOUN
gra-919	76	64	(	(	PUNCT
gra-919	76	65	%	%	NOUN
gra-919	76	66	)	)	PUNCT
gra-919	76	67	15	15	NUM
gra-919	76	68	(	(	PUNCT
gra-919	76	69	46.8	46.8	NUM
gra-919	76	70	)	)	PUNCT
gra-919	76	71	20	20	NUM
gra-919	76	72	(	(	PUNCT
gra-919	76	73	62.5	62.5	NUM
gra-919	76	74	)	)	PUNCT
gra-919	76	75	0.268	0.268	NUM
gra-919	76	76	ivh	ivh	NOUN
gra-919	76	77	(	(	PUNCT
gra-919	76	78	%	%	INTJ
gra-919	76	79	)	)	PUNCT
gra-919	76	80	16	16	NUM
gra-919	76	81	(	(	PUNCT
gra-919	76	82	51.9	51.9	NUM
gra-919	76	83	)	)	SYM
gra-919	76	84	19	19	NUM
gra-919	76	85	(	(	PUNCT
gra-919	76	86	59.3	59.3	NUM
gra-919	76	87	)	)	PUNCT
gra-919	76	88	0.409	0.409	NUM
gra-919	76	89	pvl	pvl	NOUN
gra-919	76	90	(	(	PUNCT
gra-919	76	91	%	%	NOUN
gra-919	76	92	)	)	PUNCT
gra-919	76	93	3	3	NUM
gra-919	76	94	(	(	PUNCT
gra-919	76	95	11.1	11.1	NUM
gra-919	76	96	)	)	PUNCT
gra-919	76	97	0(0	0(0	NUM
gra-919	76	98	)	)	PUNCT
gra-919	76	99	0.299	0.299	NUM
gra-919	76	100	nec	nec	PROPN
gra-919	76	101	(	(	PUNCT
gra-919	76	102	%	%	NOUN
gra-919	76	103	)	)	PUNCT
gra-919	76	104	20	20	NUM
gra-919	76	105	(	(	PUNCT
gra-919	76	106	62.5	62.5	NUM
gra-919	76	107	)	)	PUNCT
gra-919	76	108	15	15	NUM
gra-919	76	109	(	(	PUNCT
gra-919	76	110	46.8	46.8	NUM
gra-919	76	111	)	)	PUNCT
gra-919	76	112	0.273	0.273	NUM
gra-919	76	113	hie	hie	NOUN
gra-919	76	114	(	(	PUNCT
gra-919	76	115	%	%	NOUN
gra-919	76	116	)	)	PUNCT
gra-919	76	117	0	0	NUM
gra-919	76	118	(	(	PUNCT
gra-919	76	119	0	0	NUM
gra-919	76	120	)	)	SYM
gra-919	76	121	2	2	NUM
gra-919	76	122	(	(	PUNCT
gra-919	76	123	6.2	6.2	NUM
gra-919	76	124	)	)	PUNCT
gra-919	76	125	0.552	0.552	NUM
gra-919	76	126	positive	positive	ADJ
gra-919	76	127	blood	blood	NOUN
gra-919	76	128	culture	culture	NOUN
gra-919	76	129	(	(	PUNCT
gra-919	76	130	%	%	INTJ
gra-919	76	131	)	)	PUNCT
gra-919	76	132	13	13	NUM
gra-919	76	133	(	(	PUNCT
gra-919	76	134	40.6	40.6	NUM
gra-919	76	135	)	)	PUNCT
gra-919	76	136	5(15.6	5(15.6	NUM
gra-919	76	137	%	%	NOUN
gra-919	76	138	)	)	PUNCT
gra-919	77	1	0.02	0.02	NUM
gra-919	77	2	*	*	PUNCT
gra-919	77	3	no	no	INTJ
gra-919	77	4	.	.	PUNCT
gra-919	78	1	deaths	death	NOUN
gra-919	78	2	(	(	PUNCT
gra-919	78	3	%	%	INTJ
gra-919	78	4	)	)	PUNCT
gra-919	78	5	9(28.1	9(28.1	NUM
gra-919	78	6	)	)	PUNCT
gra-919	78	7	16	16	NUM
gra-919	78	8	(	(	PUNCT
gra-919	78	9	50	50	NUM
gra-919	78	10	%	%	NOUN
gra-919	78	11	)	)	PUNCT
gra-919	78	12	0.097	0.097	NUM
gra-919	78	13	invasive	invasive	ADJ
gra-919	78	14	respiratory	respiratory	ADJ
gra-919	78	15	support	support	NOUN
gra-919	78	16	22	22	NUM
gra-919	78	17	(	(	PUNCT
gra-919	78	18	68.75	68.75	NUM
gra-919	78	19	)	)	PUNCT
gra-919	78	20	26	26	NUM
gra-919	78	21	(	(	PUNCT
gra-919	78	22	81.25	81.25	NUM
gra-919	78	23	)	)	PUNCT
gra-919	78	24	0.715	0.715	NUM
gra-919	78	25	median	median	ADJ
gra-919	78	26	hospital	hospital	NOUN
gra-919	78	27	stay	stay	NOUN
gra-919	78	28	(	(	PUNCT
gra-919	78	29	d	d	NOUN
gra-919	78	30	)	)	PUNCT
gra-919	78	31	42	42	NUM
gra-919	78	32	(	(	PUNCT
gra-919	78	33	iqr	iqr	NOUN
gra-919	78	34	:	:	PUNCT
gra-919	78	35	18–79	18–79	NUM
gra-919	78	36	)	)	PUNCT
gra-919	78	37	23	23	NUM
gra-919	78	38	(	(	PUNCT
gra-919	78	39	iqr	iqr	NOUN
gra-919	78	40	:	:	PUNCT
gra-919	78	41	5–74	5–74	ADJ
gra-919	78	42	)	)	PUNCT
gra-919	78	43	median	median	ADJ
gra-919	78	44	days	day	NOUN
gra-919	78	45	on	on	ADP
gra-919	78	46	antibiotics	antibiotic	NOUN
gra-919	78	47	17	17	NUM
gra-919	78	48	(	(	PUNCT
gra-919	78	49	iqr	iqr	NOUN
gra-919	78	50	:	:	PUNCT
gra-919	78	51	9–30	9–30	NUM
gra-919	78	52	)	)	PUNCT
gra-919	78	53	13	13	NUM
gra-919	78	54	iqr	iqr	NOUN
gra-919	78	55	:	:	PUNCT
gra-919	78	56	3–25	3–25	VERB
gra-919	78	57	)	)	PUNCT
gra-919	78	58	amikacin+cloxacillin	amikacin+cloxacillin	PROPN
gra-919	78	59	cefotaxime+ampicillin	cefotaxime+ampicillin	PROPN
gra-919	78	60	staphylococcus	staphylococcus	NOUN
gra-919	78	61	epidermidis	epidermidi	NOUN
gra-919	78	62	(	(	PUNCT
gra-919	78	63	13	13	NUM
gra-919	78	64	cases	case	NOUN
gra-919	78	65	)	)	PUNCT
gra-919	78	66	,	,	PUNCT
gra-919	78	67	staphylococcus	staphylococcus	NOUN
gra-919	78	68	haemolyticus	haemolyticus	NOUN
gra-919	78	69	(	(	PUNCT
gra-919	78	70	1	1	NUM
gra-919	78	71	case	case	NOUN
gra-919	78	72	)	)	PUNCT
gra-919	78	73	,	,	PUNCT
gra-919	78	74	staphylococcus	staphylococcus	NOUN
gra-919	78	75	lugdunensis	lugdunensis	NOUN
gra-919	78	76	(	(	PUNCT
gra-919	78	77	1	1	NUM
gra-919	78	78	case	case	NOUN
gra-919	78	79	)	)	PUNCT
gra-919	78	80	,	,	PUNCT
gra-919	78	81	staphylococcus	staphylococcus	NOUN
gra-919	78	82	capitis	capitis	NOUN
gra-919	78	83	(	(	PUNCT
gra-919	78	84	1	1	NUM
gra-919	78	85	case	case	NOUN
gra-919	78	86	)	)	PUNCT
gra-919	78	87	,	,	PUNCT
gra-919	78	88	acinetobacter	acinetobacter	ADV
gra-919	78	89	baumannii	baumannii	ADJ
gra-919	78	90	(	(	PUNCT
gra-919	78	91	1	1	NUM
gra-919	78	92	case	case	NOUN
gra-919	78	93	)	)	PUNCT
gra-919	78	94	,	,	PUNCT
gra-919	78	95	enterobacter	enterobacter	ADJ
gra-919	78	96	cloacae	cloacae	NOUN
gra-919	78	97	(	(	PUNCT
gra-919	78	98	2	2	NUM
gra-919	78	99	cases	case	NOUN
gra-919	78	100	)	)	PUNCT
gra-919	78	101	,	,	PUNCT
gra-919	78	102	e.	e.	PROPN
gra-919	78	103	coli	coli	PROPN
gra-919	78	104	(	(	PUNCT
gra-919	78	105	1	1	NUM
gra-919	78	106	case	case	NOUN
gra-919	78	107	staphylococcus	staphylococcus	NOUN
gra-919	78	108	epidermidis	epidermidi	NOUN
gra-919	78	109	(	(	PUNCT
gra-919	78	110	8	8	NUM
gra-919	78	111	cases	case	NOUN
gra-919	78	112	)	)	PUNCT
gra-919	78	113	pseudomonas	pseudomona	NOUN
gra-919	78	114	aeruginosa	aeruginosa	NOUN
gra-919	78	115	(	(	PUNCT
gra-919	78	116	2	2	NUM
gra-919	78	117	cases	case	NOUN
gra-919	78	118	)	)	PUNCT
gra-919	78	119	klebsiella	klebsiella	NOUN
gra-919	78	120	(	(	PUNCT
gra-919	78	121	1	1	NUM
gra-919	78	122	case	case	NOUN
gra-919	78	123	)	)	PUNCT
gra-919	78	124	acinetobacter	acinetobacter	ADV
gra-919	78	125	baumannii	baumannii	ADJ
gra-919	78	126	(	(	PUNCT
gra-919	78	127	2	2	NUM
gra-919	78	128	cases	case	NOUN
gra-919	78	129	)	)	PUNCT
gra-919	78	130	enterobacter	enterobacter	NOUN
gra-919	78	131	cloacae	cloacae	NOUN
gra-919	78	132	(	(	PUNCT
gra-919	78	133	1	1	NUM
gra-919	78	134	case	case	NOUN
gra-919	78	135	)	)	PUNCT
gra-919	78	136	e.	e.	PROPN
gra-919	78	137	coli	coli	PROPN
gra-919	78	138	(	(	PUNCT
gra-919	78	139	1	1	NUM
gra-919	78	140	case	case	NOUN
gra-919	78	141	)	)	PUNCT
gra-919	78	142	candida	candida	PROPN
gra-919	78	143	sp	sp	PROPN
gra-919	78	144	.	.	PUNCT
gra-919	79	1	(	(	PUNCT
gra-919	79	2	1	1	NUM
gra-919	79	3	case	case	NOUN
gra-919	79	4	ndings	nding	NOUN
gra-919	79	5	.	.	PUNCT
gra-919	80	1	hence	hence	ADV
gra-919	80	2	,	,	PUNCT
gra-919	80	3	the	the	DET
gra-919	80	4	result	result	NOUN
gra-919	80	5	should	should	AUX
gra-919	80	6	be	be	AUX
gra-919	80	7	interpreted	interpret	VERB
gra-919	80	8	with	with	ADP
gra-919	80	9	caution	caution	NOUN
gra-919	80	10	.	.	PUNCT
gra-919	81	1	furthermore	furthermore	ADV
gra-919	81	2	,	,	PUNCT
gra-919	81	3	we	we	PRON
gra-919	81	4	do	do	AUX
gra-919	81	5	not	not	PART
gra-919	81	6	maintain	maintain	VERB
gra-919	81	7	a	a	DET
gra-919	81	8	central	central	ADJ
gra-919	81	9	line	line	NOUN
gra-919	81	10	-	-	PUNCT
gra-919	81	11	associated	associate	VERB
gra-919	81	12	bloodstream	bloodstream	NOUN
gra-919	81	13	infection	infection	NOUN
gra-919	81	14	database	database	NOUN
gra-919	81	15	at	at	ADP
gra-919	81	16	our	our	PRON
gra-919	81	17	center	center	NOUN
gra-919	81	18	.	.	PUNCT
gra-919	82	1	thus	thus	ADV
gra-919	82	2	,	,	PUNCT
gra-919	82	3	we	we	PRON
gra-919	82	4	are	be	AUX
gra-919	82	5	unable	unable	ADJ
gra-919	82	6	to	to	PART
gra-919	82	7	account	account	VERB
gra-919	82	8	for	for	ADP
gra-919	82	9	the	the	DET
gra-919	82	10	effect	effect	NOUN
gra-919	82	11	of	of	ADP
gra-919	82	12	these	these	DET
gra-919	82	13	infections	infection	NOUN
gra-919	82	14	on	on	ADP
gra-919	82	15	mortality	mortality	NOUN
gra-919	82	16	.	.	PUNCT
gra-919	83	1	in	in	ADP
gra-919	83	2	conclusion	conclusion	NOUN
gra-919	83	3	,	,	PUNCT
gra-919	83	4	amikacin	amikacin	PROPN
gra-919	83	5	–	–	PUNCT
gra-919	83	6	cloxacillin	cloxacillin	NOUN
gra-919	83	7	combination	combination	NOUN
gra-919	83	8	therapy	therapy	NOUN
gra-919	83	9	was	be	AUX
gra-919	83	10	associated	associate	VERB
gra-919	83	11	with	with	ADP
gra-919	83	12	lower	low	ADJ
gra-919	83	13	mortality	mortality	NOUN
gra-919	83	14	in	in	ADP
gra-919	83	15	neonates	neonate	NOUN
gra-919	83	16	with	with	ADP
gra-919	83	17	late	late	ADJ
gra-919	83	18	-	-	PUNCT
gra-919	83	19	onset	onset	NOUN
gra-919	83	20	sepsis	sepsis	NOUN
gra-919	83	21	at	at	ADP
gra-919	83	22	our	our	PRON
gra-919	83	23	nicu	nicu	NOUN
gra-919	83	24	,	,	PUNCT
gra-919	83	25	compared	compare	VERB
gra-919	83	26	with	with	ADP
gra-919	83	27	cefotaxime	cefotaxime	NOUN
gra-919	83	28	–	–	PUNCT
gra-919	83	29	ampicillin	ampicillin	NOUN
gra-919	83	30	.	.	PUNCT
gra-919	84	1	other	other	ADJ
gra-919	84	2	important	important	ADJ
gra-919	84	3	inuences	inuence	NOUN
gra-919	84	4	that	that	PRON
gra-919	84	5	can	can	AUX
gra-919	84	6	impact	impact	VERB
gra-919	84	7	mortality	mortality	NOUN
gra-919	84	8	need	need	VERB
gra-919	84	9	to	to	PART
gra-919	84	10	be	be	AUX
gra-919	84	11	investigated	investigate	VERB
gra-919	84	12	in	in	ADP
gra-919	84	13	future	future	ADJ
gra-919	84	14	studies	study	NOUN
gra-919	84	15	..	..	PUNCT
gra-919	84	16	to	to	PART
gra-919	84	17	control	control	VERB
gra-919	84	18	the	the	DET
gra-919	84	19	misuse	misuse	NOUN
gra-919	84	20	of	of	ADP
gra-919	84	21	antibiotics	antibiotic	NOUN
gra-919	84	22	,	,	PUNCT
gra-919	84	23	institutions	institution	NOUN
gra-919	84	24	need	need	VERB
gra-919	84	25	to	to	PART
gra-919	84	26	develop	develop	VERB
gra-919	84	27	clearer	clear	ADJ
gra-919	84	28	guidelines	guideline	NOUN
gra-919	84	29	based	base	VERB
gra-919	84	30	on	on	ADP
gra-919	84	31	antibiotics	antibiotic	NOUN
gra-919	84	32	prevalence	prevalence	NOUN
gra-919	84	33	and	and	CCONJ
gra-919	84	34	susceptibility	susceptibility	NOUN
gra-919	84	35	patterns	pattern	NOUN
gra-919	84	36	.	.	PUNCT
gra-919	85	1	conflict	conflict	NOUN
gra-919	85	2	of	of	ADP
gra-919	85	3	interest	interest	NOUN
gra-919	85	4	:	:	PUNCT
gra-919	85	5	none	none	NOUN
gra-919	85	6	references	reference	VERB
gra-919	85	7	1	1	NUM
gra-919	85	8	.	.	PUNCT
gra-919	85	9	registrar	registrar	PROPN
gra-919	85	10	general	general	ADJ
gra-919	85	11	of	of	ADP
gra-919	85	12	india	india	PROPN
gra-919	85	13	(	(	PUNCT
gra-919	85	14	2016).sample	2016).sample	NUM
gra-919	85	15	registration	registration	NOUN
gra-919	85	16	syatem	syatem	NOUN
gra-919	85	17	statistics	statistic	NOUN
gra-919	85	18	report	report	VERB
gra-919	85	19	2016,new	2016,new	NUM
gra-919	85	20	delhi	delhi	ADJ
gra-919	85	21	:	:	PUNCT
gra-919	85	22	registrar	registrar	NOUN
gra-919	85	23	general	general	ADJ
gra-919	85	24	of	of	ADP
gra-919	85	25	india	india	PROPN
gra-919	85	26	.	.	PUNCT
gra-919	86	1	2	2	X
gra-919	86	2	.	.	X
gra-919	86	3	national	national	PROPN
gra-919	86	4	family	family	PROPN
gra-919	86	5	health	health	NOUN
gra-919	86	6	survey	survey	NOUN
gra-919	86	7	4	4	NUM
gra-919	86	8	(	(	PUNCT
gra-919	86	9	2015	2015	NUM
gra-919	86	10	-	-	PUNCT
gra-919	86	11	16),n	16),n	NUM
gra-919	86	12	ational	ational	ADJ
gra-919	86	13	fact	fact	NOUN
gra-919	86	14	sheet	sheet	NOUN
gra-919	86	15	,	,	PUNCT
gra-919	86	16	2016	2016	NUM
gra-919	86	17	.	.	PUNCT
gra-919	87	1	3	3	X
gra-919	87	2	.	.	X
gra-919	87	3	waters	water	NOUN
gra-919	87	4	d	d	PROPN
gra-919	87	5	,	,	PUNCT
gra-919	87	6	jawad	jawad	PROPN
gra-919	87	7	i	i	PROPN
gra-919	87	8	,	,	PUNCT
gra-919	87	9	ahmad	ahmad	PROPN
gra-919	87	10	a	a	PRON
gra-919	87	11	,	,	PUNCT
gra-919	87	12	lukšic	lukšic	NOUN
gra-919	87	13	i	i	PRON
gra-919	87	14	,	,	PUNCT
gra-919	87	15	nair	nair	PROPN
gra-919	87	16	h	h	PROPN
gra-919	87	17	,	,	PUNCT
gra-919	87	18	zgaga	zgaga	PROPN
gra-919	87	19	l	l	PROPN
gra-919	87	20	,	,	PUNCT
gra-919	87	21	et	et	PROPN
gra-919	87	22	al	al	PROPN
gra-919	87	23	.	.	PROPN
gra-919	87	24	aetiology	aetiology	NOUN
gra-919	87	25	of	of	ADP
gra-919	87	26	community	community	NOUN
gra-919	87	27	-	-	PUNCT
gra-919	87	28	acquired	acquire	VERB
gra-919	87	29	neonatal	neonatal	ADJ
gra-919	87	30	sepsis	sepsis	NOUN
gra-919	87	31	in	in	ADP
gra-919	87	32	low	low	ADJ
gra-919	87	33	and	and	CCONJ
gra-919	87	34	middle	middle	ADJ
gra-919	87	35	income	income	NOUN
gra-919	87	36	countries	country	NOUN
gra-919	87	37	.	.	PUNCT
gra-919	88	1	j	j	PROPN
gra-919	88	2	glob	glob	PROPN
gra-919	88	3	health	health	NOUN
gra-919	88	4	.	.	PUNCT
gra-919	89	1	2011;1:154–170	2011;1:154–170	NUM
gra-919	89	2	4	4	NUM
gra-919	89	3	.	.	PUNCT
gra-919	89	4	bizzarro	bizzarro	PROPN
gra-919	89	5	mj	mj	PROPN
gra-919	89	6	,	,	PUNCT
gra-919	89	7	raskind	raskind	NOUN
gra-919	89	8	c	c	NOUN
gra-919	89	9	,	,	PUNCT
gra-919	89	10	baltimore	baltimore	PROPN
gra-919	89	11	rs	rs	PROPN
gra-919	89	12	,	,	PUNCT
gra-919	89	13	et	et	PROPN
gra-919	89	14	al	al	PROPN
gra-919	89	15	.	.	PUNCT
gra-919	90	1	seventy-ve	seventy-ve	NUM
gra-919	90	2	years	year	NOUN
gra-919	90	3	of	of	ADP
gra-919	90	4	neonatal	neonatal	ADJ
gra-919	90	5	sepsis	sepsis	NOUN
gra-919	90	6	at	at	ADP
gra-919	90	7	yale	yale	PROPN
gra-919	90	8	:	:	PUNCT
gra-919	90	9	1928–2003	1928–2003	NUM
gra-919	90	10	.	.	PUNCT
gra-919	90	11	pediatrics	pediatric	NOUN
gra-919	90	12	2005;116:595–602	2005;116:595–602	NUM
gra-919	90	13	.	.	PUNCT
gra-919	91	1	5	5	X
gra-919	91	2	.	.	X
gra-919	91	3	shim	shim	PROPN
gra-919	91	4	gh	gh	PROPN
gra-919	91	5	,	,	PUNCT
gra-919	91	6	kim	kim	PROPN
gra-919	91	7	sd	sd	PROPN
gra-919	91	8	,	,	PUNCT
gra-919	91	9	kim	kim	PROPN
gra-919	91	10	hs	hs	PROPN
gra-919	91	11	,	,	PUNCT
gra-919	91	12	et	et	NOUN
gra-919	91	13	al.trends	al.trend	NOUN
gra-919	91	14	in	in	ADP
gra-919	91	15	epidemiology	epidemiology	NOUN
gra-919	91	16	of	of	ADP
gra-919	91	17	neonatal	neonatal	ADJ
gra-919	91	18	sepsis	sepsis	NOUN
gra-919	91	19	in	in	ADP
gra-919	91	20	a	a	DET
gra-919	91	21	tertiary	tertiary	ADJ
gra-919	91	22	center	center	NOUN
gra-919	91	23	in	in	ADP
gra-919	91	24	korea	korea	PROPN
gra-919	91	25	:	:	PUNCT
gra-919	91	26	a	a	DET
gra-919	91	27	26	26	NUM
gra-919	91	28	-	-	PUNCT
gra-919	91	29	year	year	NOUN
gra-919	91	30	longitudinal	longitudinal	ADJ
gra-919	91	31	analysis	analysis	NOUN
gra-919	91	32	,	,	PUNCT
gra-919	91	33	1980–2005	1980–2005	NUM
gra-919	91	34	.	.	PUNCT
gra-919	92	1	j	j	PROPN
gra-919	92	2	korean	korean	PROPN
gra-919	92	3	med	med	PROPN
gra-919	92	4	sci	sci	PROPN
gra-919	92	5	2011;26:284–9	2011;26:284–9	NUM
gra-919	92	6	.	.	PROPN
gra-919	92	7	6	6	NUM
gra-919	92	8	.	.	X
gra-919	92	9	fuchs	fuchs	PROPN
gra-919	92	10	a	a	PRON
gra-919	92	11	,	,	PUNCT
gra-919	92	12	bielicki	bielicki	PROPN
gra-919	92	13	et	et	PROPN
gra-919	92	14	al.antibiotic	al.antibiotic	ADJ
gra-919	92	15	sepsis	sepsis	NOUN
gra-919	92	16	use	use	NOUN
gra-919	92	17	for	for	ADP
gra-919	92	18	the	the	DET
gra-919	92	19	neonates	neonate	NOUN
gra-919	92	20	and	and	CCONJ
gra-919	92	21	children.2016	children.2016	PROPN
gra-919	92	22	evidence	evidence	NOUN
gra-919	92	23	update.who	update.who	PRON
gra-919	92	24	reviews	review	VERB
gra-919	92	25	2016	2016	NUM
gra-919	92	26	7	7	NUM
gra-919	92	27	.	.	PUNCT
gra-919	93	1	van	van	PROPN
gra-919	93	2	den	den	PROPN
gra-919	93	3	hoogen	hoogen	PROPN
gra-919	93	4	a	a	DET
gra-919	93	5	,	,	PUNCT
gra-919	93	6	gerards	gerards	ADP
gra-919	93	7	lj	lj	PROPN
gra-919	93	8	,	,	PUNCT
gra-919	93	9	verboon	verboon	ADV
gra-919	93	10	-	-	PUNCT
gra-919	93	11	maciolek	maciolek	NOUN
gra-919	93	12	ma	ma	PROPN
gra-919	93	13	,	,	PUNCT
gra-919	93	14	fleer	fleer	NOUN
gra-919	93	15	a	a	PRON
gra-919	93	16	,	,	PUNCT
gra-919	93	17	krediet	krediet	PROPN
gra-919	93	18	tg	tg	PROPN
gra-919	93	19	.	.	PUNCT
gra-919	93	20	long	long	ADJ
gra-919	93	21	-	-	PUNCT
gra-919	93	22	term	term	NOUN
gra-919	93	23	trends	trend	NOUN
gra-919	93	24	in	in	ADP
gra-919	93	25	the	the	DET
gra-919	93	26	epidemiology	epidemiology	NOUN
gra-919	93	27	of	of	ADP
gra-919	93	28	neonatal	neonatal	ADJ
gra-919	93	29	sepsis	sepsis	NOUN
gra-919	93	30	and	and	CCONJ
gra-919	93	31	antibiotic	antibiotic	ADJ
gra-919	93	32	susceptibility	susceptibility	NOUN
gra-919	93	33	of	of	ADP
gra-919	93	34	causative	causative	ADJ
gra-919	93	35	agents	agent	NOUN
gra-919	93	36	.	.	PUNCT
gra-919	94	1	neonatology	neonatology	NOUN
gra-919	94	2	2010;97:22	2010;97:22	NUM
gra-919	94	3	-	-	SYM
gra-919	94	4	8	8	NUM
gra-919	94	5	.	.	NOUN
gra-919	94	6	8	8	NUM
gra-919	94	7	.	.	PUNCT
gra-919	94	8	leal	leal	PROPN
gra-919	94	9	ya	ya	PROPN
gra-919	94	10	,	,	PUNCT
gra-919	94	11	álvarez	álvarez	NOUN
gra-919	94	12	-	-	PUNCT
gra-919	94	13	nemegyei	nemegyei	PROPN
gra-919	94	14	j	j	PROPN
gra-919	94	15	,	,	PUNCT
gra-919	94	16	velázquez	velázquez	PROPN
gra-919	94	17	jr	jr	PROPN
gra-919	94	18	,	,	PUNCT
gra-919	94	19	rosado	rosado	NOUN
gra-919	94	20	-	-	PUNCT
gra-919	94	21	quiab	quiab	NOUN
gra-919	94	22	u	u	NOUN
gra-919	94	23	,	,	PUNCT
gra-919	94	24	diegorodríguez	diegorodríguez	NOUN
gra-919	94	25	n	n	SYM
gra-919	94	26	,	,	PUNCT
gra-919	94	27	paz	paz	NOUN
gra-919	94	28	-	-	PUNCT
gra-919	94	29	baeza	baeza	PROPN
gra-919	94	30	e	e	PROPN
gra-919	94	31	,	,	PUNCT
gra-919	94	32	et	et	PROPN
gra-919	94	33	al	al	PROPN
gra-919	94	34	.	.	PUNCT
gra-919	95	1	risk	risk	NOUN
gra-919	95	2	factors	factor	NOUN
gra-919	95	3	and	and	CCONJ
gra-919	95	4	prognosis	prognosis	NOUN
gra-919	95	5	for	for	ADP
gra-919	95	6	neonatal	neonatal	ADJ
gra-919	95	7	sepsis	sepsis	NOUN
gra-919	95	8	in	in	ADP
gra-919	95	9	southeastern	southeastern	ADJ
gra-919	95	10	mexico	mexico	PROPN
gra-919	95	11	:	:	PUNCT
gra-919	95	12	analysis	analysis	NOUN
gra-919	95	13	of	of	ADP
gra-919	95	14	a	a	DET
gra-919	95	15	four	four	NUM
gra-919	95	16	-	-	PUNCT
gra-919	95	17	year	year	NOUN
gra-919	95	18	historic	historic	ADJ
gra-919	95	19	cohort	cohort	NOUN
gra-919	95	20	followup	followup	NOUN
gra-919	95	21	.	.	PUNCT
gra-919	96	1	bmc	bmc	ADJ
gra-919	96	2	pregnancy	pregnancy	NOUN
gra-919	96	3	childbirth	childbirth	NOUN
gra-919	96	4	2012;12	2012;12	NUM
gra-919	96	5	9	9	NUM
gra-919	96	6	.	.	PUNCT
gra-919	97	1	al	al	PROPN
gra-919	97	2	mouqadad	mouqadad	PROPN
gra-919	97	3	mm	mm	PROPN
gra-919	97	4	,	,	PUNCT
gra-919	97	5	alaklobi	alaklobi	NOUN
gra-919	97	6	et	et	PROPN
gra-919	97	7	al	al	PROPN
gra-919	97	8	.	.	PUNCT
gra-919	98	1	a	a	DET
gra-919	98	2	retrospective	retrospective	ADJ
gra-919	98	3	cohort	cohort	NOUN
gra-919	98	4	study	study	NOUN
gra-919	98	5	patient	patient	ADJ
gra-919	98	6	chart	chart	NOUN
gra-919	98	7	review	review	NOUN
gra-919	98	8	of	of	ADP
gra-919	98	9	neonatal	neonatal	ADJ
gra-919	98	10	sepsis	sepsis	NOUN
gra-919	98	11	investigating	investigate	VERB
gra-919	98	12	responsible	responsible	ADJ
gra-919	98	13	microorganisms	microorganism	NOUN
gra-919	98	14	and	and	CCONJ
gra-919	98	15	their	their	PRON
gra-919	98	16	susceptibility	susceptibility	NOUN
gra-919	98	17	.	.	PUNCT
gra-919	99	1	j	j	PROPN
gra-919	99	2	clin	clin	PROPN
gra-919	99	3	neonatal	neonatal	PROPN
gra-919	99	4	.	.	PUNCT
gra-919	100	1	2018:7	2018:7	NUM
gra-919	100	2	141	141	NUM
gra-919	100	3	-	-	SYM
gra-919	100	4	145	145	NUM
gra-919	100	5	10	10	NUM
gra-919	100	6	.	.	PUNCT
gra-919	101	1	russel	russel	PROPN
gra-919	101	2	ab	ab	PROPN
gra-919	101	3	,	,	PUNCT
gra-919	101	4	sharland	sharland	PROPN
gra-919	101	5	m	m	PROPN
gra-919	101	6	,	,	PUNCT
gra-919	101	7	improving	improve	VERB
gra-919	101	8	antibiotic	antibiotic	ADJ
gra-919	101	9	prescribing	prescribing	NOUN
gra-919	101	10	in	in	ADP
gra-919	101	11	neonatal	neonatal	ADJ
gra-919	101	12	units	unit	NOUN
gra-919	101	13	,	,	PUNCT
gra-919	101	14	time	time	NOUN
gra-919	101	15	to	to	PART
gra-919	101	16	act	act	VERB
gra-919	101	17	.	.	PUNCT
gra-919	102	1	arch	arch	PROPN
gra-919	102	2	dis	dis	PROPN
gra-919	102	3	child	child	PROPN
gra-919	102	4	fetal	fetal	ADJ
gra-919	102	5	neonatal	neonatal	ADJ
gra-919	102	6	ed.2012	ed.2012	PROPN
gra-919	102	7	11	11	NUM
gra-919	102	8	.	.	PUNCT
gra-919	103	1	wynn	wynn	PROPN
gra-919	103	2	jl	jl	PROPN
gra-919	103	3	.	.	PUNCT
gra-919	104	1	de	de	PROPN
gra-919	104	2	�	�	PROPN
gra-919	104	3	ning	ning	ADJ
gra-919	104	4	neonatal	neonatal	ADJ
gra-919	104	5	sepsis	sepsis	NOUN
gra-919	104	6	.	.	PUNCT
gra-919	105	1	curr	curr	PROPN
gra-919	105	2	opin	opin	NOUN
gra-919	105	3	pediatr	pediatr	NOUN
gra-919	105	4	.	.	PUNCT
gra-919	106	1	2016;28:135–140	2016;28:135–140	NUM
gra-919	106	2	12	12	NUM
gra-919	106	3	.	.	PUNCT
gra-919	107	1	metsvaht	metsvaht	PROPN
gra-919	107	2	t	t	PROPN
gra-919	107	3	,	,	PUNCT
gra-919	107	4	ilmoja	ilmoja	NOUN
gra-919	107	5	ml	ml	PROPN
gra-919	107	6	,	,	PUNCT
gra-919	107	7	parm	parm	PROPN
gra-919	107	8	ü	ü	PROPN
gra-919	107	9	,	,	PUNCT
gra-919	107	10	et	et	PROPN
gra-919	107	11	al	al	PROPN
gra-919	107	12	.	.	PROPN
gra-919	107	13	comparison	comparison	NOUN
gra-919	107	14	of	of	ADP
gra-919	107	15	ampicillin	ampicillin	NOUN
gra-919	107	16	plus	plus	CCONJ
gra-919	107	17	gentamicin	gentamicin	NOUN
gra-919	107	18	vs.	vs.	ADP
gra-919	107	19	penicillin	penicillin	NOUN
gra-919	107	20	plus	plus	CCONJ
gra-919	107	21	gentamicin	gentamicin	VERB
gra-919	107	22	in	in	ADP
gra-919	107	23	empiric	empiric	ADJ
gra-919	107	24	treatment	treatment	NOUN
gra-919	107	25	of	of	ADP
gra-919	107	26	neonates	neonate	NOUN
gra-919	107	27	at	at	ADP
gra-919	107	28	risk	risk	NOUN
gra-919	107	29	of	of	ADP
gra-919	107	30	early	early	ADJ
gra-919	107	31	onset	onset	NOUN
gra-919	107	32	sepsis	sepsis	NOUN
gra-919	107	33	.	.	PUNCT
gra-919	108	1	acta	acta	PROPN
gra-919	108	2	paediatr	paediatr	NOUN
gra-919	108	3	.	.	PUNCT
gra-919	109	1	2010;99:665–672	2010;99:665–672	NUM
gra-919	109	2	13	13	NUM
gra-919	109	3	.	.	PUNCT
gra-919	110	1	hornik	hornik	PROPN
gra-919	110	2	cp	cp	PROPN
gra-919	110	3	,	,	PUNCT
gra-919	110	4	fort	fort	NOUN
gra-919	110	5	p	p	PROPN
gra-919	110	6	,	,	PUNCT
gra-919	110	7	clark	clark	PROPN
gra-919	110	8	rh	rh	PROPN
gra-919	110	9	,	,	PUNCT
gra-919	110	10	et	et	PROPN
gra-919	110	11	al	al	PROPN
gra-919	110	12	.	.	PROPN
gra-919	111	1	early	early	ADJ
gra-919	111	2	and	and	CCONJ
gra-919	111	3	late	late	ADJ
gra-919	111	4	onset	onset	VERB
gra-919	111	5	sepsis	sepsis	NOUN
gra-919	111	6	in	in	ADP
gra-919	111	7	very	very	ADV
gra-919	111	8	-	-	PUNCT
gra-919	111	9	low	low	ADJ
gra-919	111	10	-	-	PUNCT
gra-919	111	11	birthweight	birthweight	ADJ
gra-919	111	12	infants	infant	NOUN
gra-919	111	13	from	from	ADP
gra-919	111	14	a	a	DET
gra-919	111	15	large	large	ADJ
gra-919	111	16	group	group	NOUN
gra-919	111	17	of	of	ADP
gra-919	111	18	neonatal	neonatal	ADJ
gra-919	111	19	intensive	intensive	ADJ
gra-919	111	20	care	care	NOUN
gra-919	111	21	units	unit	NOUN
gra-919	111	22	.	.	PUNCT
gra-919	112	1	early	early	ADV
gra-919	112	2	hum	hum	NOUN
gra-919	113	1	dev.2012;88(suppl	dev.2012;88(suppl	PROPN
gra-919	113	2	2):s69	2):s69	NUM
gra-919	113	3	–	–	PUNCT
gra-919	113	4	s74	s74	PRON
gra-919	113	5	14	14	NUM
gra-919	113	6	.	.	PUNCT
gra-919	114	1	muller	muller	NOUN
gra-919	114	2	-	-	PUNCT
gra-919	114	3	pebody	pebody	PROPN
gra-919	114	4	b	b	PROPN
gra-919	114	5	,	,	PUNCT
gra-919	114	6	johnson	johnson	PROPN
gra-919	114	7	ap	ap	PROPN
gra-919	114	8	,	,	PUNCT
gra-919	114	9	heath	heath	PROPN
gra-919	114	10	pt	pt	PROPN
gra-919	114	11	,	,	PUNCT
gra-919	114	12	et	et	PROPN
gra-919	114	13	al	al	PROPN
gra-919	114	14	;	;	PUNCT
gra-919	114	15	icap	icap	NOUN
gra-919	114	16	group	group	NOUN
gra-919	114	17	(	(	PUNCT
gra-919	114	18	improving	improve	VERB
gra-919	114	19	antibiotic	antibiotic	ADJ
gra-919	114	20	prescribing	prescribing	NOUN
gra-919	114	21	in	in	ADP
gra-919	114	22	primary	primary	ADJ
gra-919	114	23	care	care	NOUN
gra-919	114	24	)	)	PUNCT
gra-919	114	25	.	.	PUNCT
gra-919	115	1	empirical	empirical	ADJ
gra-919	115	2	treatment	treatment	NOUN
gra-919	115	3	of	of	ADP
gra-919	115	4	neonatal	neonatal	ADJ
gra-919	115	5	sepsis	sepsis	NOUN
gra-919	115	6	:	:	PUNCT
gra-919	115	7	are	be	AUX
gra-919	115	8	the	the	DET
gra-919	115	9	current	current	ADJ
gra-919	115	10	guidelines	guideline	NOUN
gra-919	115	11	adequate	adequate	ADJ
gra-919	115	12	?	?	PUNCT
gra-919	116	1	arch	arch	PROPN
gra-919	116	2	dis	dis	PROPN
gra-919	116	3	child	child	PROPN
gra-919	116	4	fetal	fetal	ADJ
gra-919	116	5	neonatal	neonatal	ADJ
gra-919	116	6	ed	ed	NOUN
gra-919	116	7	.	.	PUNCT
gra-919	116	8	2011;96	2011;96	NUM
gra-919	116	9	:	:	PUNCT
gra-919	116	10	f4	f4	ADJ
gra-919	116	11	–	–	PUNCT
gra-919	116	12	f8	f8	PROPN
gra-919	116	13	.	.	PUNCT
gra-919	117	1	15	15	NUM
gra-919	117	2	.	.	X
gra-919	117	3	de	de	PROPN
gra-919	117	4	man	man	PROPN
gra-919	117	5	p	p	NOUN
gra-919	117	6	,	,	PUNCT
gra-919	117	7	verhoeven	verhoeven	PROPN
gra-919	117	8	ba	ba	PROPN
gra-919	117	9	,	,	PUNCT
gra-919	117	10	verbrugh	verbrugh	PROPN
gra-919	117	11	ha	ha	INTJ
gra-919	117	12	,	,	PUNCT
gra-919	117	13	et	et	PROPN
gra-919	117	14	al	al	PROPN
gra-919	117	15	.	.	PUNCT
gra-919	118	1	an	an	DET
gra-919	118	2	antibiotic	antibiotic	ADJ
gra-919	118	3	policy	policy	NOUN
gra-919	118	4	to	to	PART
gra-919	118	5	prevent	prevent	VERB
gra-919	118	6	emergence	emergence	NOUN
gra-919	118	7	of	of	ADP
gra-919	118	8	resistant	resistant	ADJ
gra-919	118	9	bacilli	bacilli	NOUN
gra-919	118	10	.	.	PUNCT
gra-919	119	1	lancet	lancet	PROPN
gra-919	119	2	.	.	PUNCT
gra-919	120	1	2000;355:973–978	2000;355:973–978	PRON
gra-919	120	2	16	16	NUM
gra-919	120	3	.	.	PUNCT
gra-919	121	1	clark	clark	PROPN
gra-919	121	2	rh	rh	PROPN
gra-919	121	3	,	,	PUNCT
gra-919	121	4	bloom	bloom	NOUN
gra-919	121	5	bt	bt	PROPN
gra-919	121	6	,	,	PUNCT
gra-919	121	7	spitzer	spitzer	PROPN
gra-919	121	8	ar	ar	PROPN
gra-919	121	9	,	,	PUNCT
gra-919	121	10	et	et	PROPN
gra-919	121	11	al	al	PROPN
gra-919	121	12	.	.	PROPN
gra-919	121	13	empiric	empiric	ADJ
gra-919	121	14	use	use	NOUN
gra-919	121	15	of	of	ADP
gra-919	121	16	ampicillin	ampicillin	NOUN
gra-919	121	17	and	and	CCONJ
gra-919	121	18	cefotaxime	cefotaxime	NOUN
gra-919	121	19	,	,	PUNCT
gra-919	121	20	compared	compare	VERB
gra-919	121	21	with	with	ADP
gra-919	121	22	ampicillin	ampicillin	NOUN
gra-919	121	23	and	and	CCONJ
gra-919	121	24	gentamicin	gentamicin	NOUN
gra-919	121	25	,	,	PUNCT
gra-919	121	26	for	for	ADP
gra-919	121	27	neo	neo	NOUN
gra-919	121	28	-	-	NOUN
gra-919	121	29	nates	nate	NOUN
gra-919	121	30	at	at	ADP
gra-919	121	31	risk	risk	NOUN
gra-919	121	32	for	for	ADP
gra-919	121	33	sepsis	sepsis	NOUN
gra-919	121	34	is	be	AUX
gra-919	121	35	associated	associate	VERB
gra-919	121	36	with	with	ADP
gra-919	121	37	an	an	DET
gra-919	121	38	increased	increase	VERB
gra-919	121	39	risk	risk	NOUN
gra-919	121	40	of	of	ADP
gra-919	121	41	neo	neo	ADJ
gra-919	121	42	-	-	ADJ
gra-919	121	43	natal	natal	ADJ
gra-919	121	44	death	death	NOUN
gra-919	121	45	.	.	PUNCT
gra-919	122	1	pediatrics	pediatric	NOUN
gra-919	122	2	.	.	PUNCT
gra-919	123	1	2006;117:67–74	2006;117:67–74	NUM
gra-919	123	2	.	.	NOUN
gra-919	123	3	17	17	NUM
gra-919	123	4	.	.	PUNCT
gra-919	124	1	aliaga	aliaga	PROPN
gra-919	124	2	s	s	PROPN
gra-919	124	3	,	,	PUNCT
gra-919	124	4	clark	clark	PROPN
gra-919	124	5	rh	rh	PROPN
gra-919	124	6	,	,	PUNCT
gra-919	124	7	laughon	laughon	PROPN
gra-919	124	8	m	m	PROPN
gra-919	124	9	,	,	PUNCT
gra-919	124	10	et	et	PROPN
gra-919	124	11	al	al	PROPN
gra-919	124	12	.	.	PROPN
gra-919	124	13	changes	change	NOUN
gra-919	124	14	in	in	ADP
gra-919	124	15	the	the	DET
gra-919	124	16	inci	inci	NOUN
gra-919	124	17	-	-	PUNCT
gra-919	124	18	dence	dence	NOUN
gra-919	124	19	of	of	ADP
gra-919	124	20	candidiasis	candidiasis	NOUN
gra-919	124	21	in	in	ADP
gra-919	124	22	neonatal	neonatal	ADJ
gra-919	124	23	intensive	intensive	ADJ
gra-919	124	24	care	care	NOUN
gra-919	124	25	units	unit	NOUN
gra-919	124	26	.	.	PUNCT
gra-919	125	1	pediatrics	pediatric	NOUN
gra-919	125	2	.	.	PUNCT
gra-919	126	1	2014;133:236–242	2014;133:236–242	NUM
gra-919	126	2	x	x	SYM
gra-919	126	3	81gjra	81gjra	PROPN
gra-919	126	4	global	global	ADJ
gra-919	126	5	journal	journal	PROPN
gra-919	126	6	for	for	ADP
gra-919	126	7	research	research	NOUN
gra-919	126	8	analysis	analysis	NOUN
gra-919	126	9	volume-8	volume-8	NUM
gra-919	126	10	,	,	PUNCT
gra-919	126	11	issue-12	issue-12	NOUN
gra-919	126	12	,	,	PUNCT
gra-919	126	13	december-2019	december-2019	ADJ
gra-919	126	14	•	•	NUM
gra-919	126	15	print	print	NOUN
gra-919	126	16	issn	issn	PROPN
gra-919	126	17	no	no	NOUN
gra-919	126	18	.	.	PROPN
gra-919	126	19	2277	2277	NUM
gra-919	126	20	8160	8160	NUM
gra-919	126	21	•	•	NOUN
gra-919	126	22	doi	doi	NOUN
gra-919	126	23	:	:	PUNCT
gra-919	126	24	10.36106	10.36106	NUM
gra-919	126	25	/	/	SYM
gra-919	126	26	gjra	gjra	NOUN